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Abstract 
 
 
MLCK/actin Interaction in the Contracting A7r5 Cell and Vascular Smooth Muscle 
 
By Sean Eric Thatcher 
 
Myosin light chain kinase (MLCK) is an enzyme that phosphorylates the serine-19 
residue on myosin regulatory light chains (MLCs) which serves to activate the Mg2+-
ATPase of myosin.  This catalytic activity is thought to be the primary role of MLCK; 
however, it has recently been suggested that MLCK’s actin binding and bundling 
properties may also be of importance in smooth muscle contraction.  In the absence of 
calcium and calmodulin (CaM), MLCK will bundle actin filaments with its N-terminus.  
During calcium influx and subsequent CaM activation, MLCK binding to actin decreases 
resulting in unbundling of actin filaments and allows myosin and actin to slide past each 
other for force development.  Despite these signals, some contractile agonists develop 
high levels of force in the relative absence of increased levels of intracellular calcium or 
MLC phosphorylation.  One agonist that falls into this category is phorbol 12,13-
dibutyrate (PDBu).  PDBu activates the protein kinase C (PKCα) pathway which inhibits 
myosin light chain phosphatase (MLCP) and allows the MLCs to stay in a 
phosphorylated state.  PKCα can also phosphorylate the kinase domain of MLCK and 
inhibit activation via CaM.  This pathway suggests that MLCK and its ability to bind to 
actin filaments may still be intact in PDBu-stimulated smooth muscle.  Therefore, the 
present studies look at the interaction between MLCK and α- and β-actin, the two 
predominant isoforms found in vascular smooth muscle, during PDBu-induced 
contraction of A7r5 smooth muscle cells in culture and highly differentiated vascular 
smooth muscle freshly excised from the rat.      
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Chapter One 
 
I.  Dissertation Organization and Literature Review 
 
 This dissertation is divided into four chapters with the first chapter discussing 
organization and giving a brief overview on MLCK function and aspects of skeletal 
versus smooth muscle contraction.  Topics on fluorescence resonance energy transfer 
(FRET) and confocal imaging will also be evaluated along with podosome structure in 
the A7r5 cell.  Similarities and differences between podosomes and invadopodia, a 
structure found in cancerous cell models, will also be discussed. 
 The second chapter deals with the N-terminal region of MLCK in the A7r5 cell 
and its interaction with α- and β-actin.  Techniques utilized in these studies were:  FRET, 
ribonucleic acid interference (RNAi), microinjection of peptides, and time-lapse phase 
contrast microscopy.   
 The third chapter looks at MLCK interaction with α- and β-actin in rat aortae.  
Techniques applied in this chapter were:  FRET, co-immunoprecipitations, and confocal 
imaging.   
 The final chapter summarizes the data collected and implications for its use in 
understanding current pathophysiological states in the cardiovascular system.  
Furthermore, a discussion on future experiments as well as the development of novel 
techniques in the arena of smooth muscle cell migration will be discussed. 
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II.  Aspects of Muscle Contraction 
 
 Typically when evaluating smooth muscle biology, comparisons are made 
between it and skeletal muscle.  Skeletal muscle forms a striated appearance due to the 
presence of sarcomeres, overlapping regions of two filamentous proteins, actin and 
myosin.  Actin and myosin interact in the central portion of the skeletal muscle sarcomere 
and is referred to as the A-band.  The outer portion of the sarcomere contains only actin 
filaments, referred to as the I-band, and this region shortens during contraction.  These 
actin filaments then attach to a region at the end of the skeletal muscle sarcomere referred 
to as the Z-line.  The Z-lines define a single sarcomere.  Many sarcomeres make up a 
myofibril and many myofibrils make up a skeletal muscle fiber.  This highly structured 
appearance has given insight into skeletal muscle contraction; however, smooth muscle 
does not have this same phenotype.  Smooth muscle, as its name implies, has a smooth 
appearance with actin and myosin arranged in various spatial patterns which rearrange 
upon contraction.  Moreover, actin and myosin may undergo a change in organization in 
the contracting cell that is referred to as remodeling.  The nature and mechanism of 
remodeling is not fully understood, but it is thought to exist since smooth muscle has the 
ability to shorten up to 80% of its original length (skeletal muscle can only shorten up to 
30%).  Hence,  remodeling during contraction requires a coordinated reshaping of the 
contractile apparatus and the cytoskeleton of smooth muscle cells (Small and Gimona, 
1998).  The contractile apparatus of smooth muscle contains muscle actin and myosin 
with other proteins required for contraction (e.g. MLCK, CaM).  The cytoskeleton is 
composed of non-muscle actin, desmin and/or vinculin, filamin, alpha-actinin, as well as 
other proteins.  It is thought that the contractile apparatus is responsible for force 
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development in smooth muscle, while the cytoskeleton is involved in transmission of 
force to adjacent cells as well as tension maintenance (North et al., 1994).  The 
contractile apparatus in smooth muscle is similar to skeletal muscle in that actin and 
myosin must slide past each other for shortening of the cell and force development.  
Since smooth muscle has the ability to maintain tension for long periods of time at low 
energy costs, it is thought that smooth muscle myosin “latches” onto the actin filament in 
the ADP-dependent state.  This hypothesis is referred to as the latch model of smooth 
muscle contraction (Murphy et al., 1987), but since then smooth muscle myosins have 
been found to come in a number of different subtypes.   
Myosin 
Myosin II is the primary isoform found in muscle and is expressed in cardiac, 
skeletal, and smooth muscle tissues.  Smooth muscle myosin ATPase is slower than its 
skeletal muscle counterpart.  This is due either to the time-dependent release of the 
inorganic phosphate or the ADP molecule itself (Karagiannis and Brozovich, 2003).  Two 
different isoforms of myosin II, which display differences in amino acid composition in 
the loop 1 region of the myosin head, are found in smooth muscle.  One isoform has a 7 
amino acid insert that is 20 amino acids away from the myosin ATPase site (Karagiannis 
and Brozovich, 2003).  This isoform is referred to as SM-B.  The other isoform does not 
contain this insert and is called SM-A.  SM-B and SM-A can exist in other types of 
myosin, such as non-muscle myosin and myosin V; however their function is the same, to 
affect the kinetics of ATP hydrolysis at the myosin active site.   SM-B is known to have a 
higher Vmax than SM-A and knockouts of SM-B in smooth muscle indicate decreases in 
shortening velocity and increases in force generation (Babu et al., 2004).  The Babu et al. 
 4
(2004) study also noted that calponin levels increased in SM-B knockouts, while 
caldesmon levels were reduced.  It is unknown at this point if SM-A or SM-B interacts 
with only certain thin filament-associated proteins.  Another variation that can occur with 
myosin is at the tail region.  Myosin consists of a hexamer of proteins that includes two 
heavy chains with two pairs of light chains.  The tail region of the carboxy terminus (C-
terminal) of myosin induces heavy chain dimers (Rovner et al., 2002).  C-terminal 
myosin isoforms can be formed through alternative splicing of the gene.  If a 43 amino 
acid insert is present then it is called SM-1.  SM-1 contains a serine site that can become 
phosphorylated by casein kinase II and is thought to effect filament assembly in some 
types of smooth muscle (Rovner et al., 2002).  The other isoform does not contain this 
insert and is referred to as SM-2.  SM-1 and SM-2 have been shown to not affect ATPase 
kinetics therefore their regulation in contraction is unclear (Trybus, 1996b).  However, it 
has been shown that the tail region of these isoforms can affect packing and assembly of 
the myosin filaments which may provide a role in structural dynamics of smooth muscle 
(Rovner et al., 2002).  Ratios of SM-1 and SM-2 can change under certain conditions, 
such as pregnancy.  There are also differences in their composition in tissues and cultured 
cell lines.  Typically, vascular smooth muscle cells have more SM-1 than SM-2 in culture 
conditions (Adelstein and Sellers, 1996).  
Actin 
Actin exists as a globular protein known as G-actin and through ATP hydrolysis 
can form filaments known as (filamentous) F-actin.  This creates a filament with polar 
ends and polymerization of actin can be influenced by proteins, such as the Arp 2/3 
complex (Lehman et al., 1996).  For polymerization to occur, an ATP molecule and a 
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divalent cation (Mg2+) must be present (Lehman et al., 1996).  Actin has a number of 
different isoforms and can exist as either a contractile-type or cytoplasmic-type of actin.  
The contractile-type is alpha (α-) or gamma (γ-) actin in smooth muscle.  α-Actin is found 
in vascular smooth muscle and γ-actin is expressed in intestinal, esophageal, and tracheal 
smooth muscle.  γ-Actin differs from α-actin in its biochemical and mechanical 
properties.  Cytoplasmic actins (β- and γ-) are expressed in all tissues and can function in 
muscle contraction and structural integrity of the cytoskeleton.  Actin structure is highly 
conserved with 95% or more of the amino acid sequence identical among these isoforms 
(Chaponnier and Gabbiani, 2004).  Smooth muscle α-actin and γ-actin differ by only four 
amino acid residues at positions 1,4,5, and 360; whereas the contractile actins differ from 
cytoplasmic actins in positions 1,2,3, and 9 (Chaponnier and Gabbiani, 2004).  One 
question that remains unanswered is whether these minor variations in the N-terminus 
convey functional differences among the actin isoforms in smooth muscle. 
Cytoskeletal Remodeling 
Through the use of in vitro motility assays and purification of F-actin, it has been 
shown that smooth muscle myosin ATPase shows no difference in the presence of 
skeletal or smooth muscle F-actin (Trybus, 1996a).  It is thought that differences in actin 
remodeling of muscle is attributed to actin-binding proteins and differences in abundance 
of these proteins.  For example, smooth muscle myosin can be expressed at 20% of the 
level of skeletal muscle (Murphy et al., 1997).  This creates actin:myosin ratios of 10-
15:1 in smooth muscle.  How or whether myosin interacts with all of the actin present in 
smooth muscle is a question that remains unanswered.  There are a number of actin- and 
myosin-binding proteins thought to influence smooth muscle contractile dynamics.  
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Caldesmon, calponin, and MLCK all occur in smooth muscle and are thought to 
modulate smooth muscle contraction (Gimona and Small, 1996, Marston and Huber, 
1996, Stull et al., 1996).  Relevant to the present studies, MLCK, found at high 
concentration in smooth muscle, is expressed at high levels early in embryology for 
skeletal and cardiac muscle, but this enzyme is absent in the adult tissue (Birukov et al., 
1998).  The finding that this or other actin-binding proteins interact with specific 
isoforms of actin could be important in our understanding of smooth muscle contraction.  
α-Actin and β-actin have been found to function differently in the A7r5 smooth muscle 
cell (Battistella-Patterson et al., 1997, Fultz et al., 2000, Li et al., 2001b).  α -Actin 
remodels into podosomes while β-actin remains in filament structure; it was proposed 
that β-actin filaments maintain tension in the cytoskeleton while reorganization of α-actin 
was responsible for generating tension in the cell.  This form of actin remodeling was 
referred to as asynchronous activation/inactivation (Battistella-Patterson et al., 1997).  
Phorbol esters induce podosomes in A7r5 cells and cause a slow but robust contraction in 
vascular smooth muscle tissue.  In comparison to the potassium depolarization (Ca2+-
induced), two phases of tension generation can be identified and have been referred to as 
the fast-phase and the slow-phase of contraction (Battistella-Patterson et al., 1997) 
(Figure 1).  The initial stimulus is an influx of calcium from the sarcoplasmic reticulum, 
extracellular space, or both into the cytosol that then binds to the CaM molecule.  For the 
potassium contraction, calcium levels rise approximately 10-fold, but this can be less 
with other contractile agonists (Kamm and Stull, 1985, Nakajima et al., 1993, Oishi et al., 
1991).  This signaling cascade results in MLCK activation and MLC phosphorylation 
(Figure 1).  
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Figure 1.  MLC phosphorylation, intracellular calcium levels, degree of shortening, and 
isometric tension in vascular smooth muscle.  The contractile stimulus is 80 mM 
potassium.  Green represents MLC, blue represents intracellular calcium, red represents 
degree of shortening, and black represents tension in grams.  Taken from (Battistella-
Patterson et al., 1997, Kamm and Stull, 1985) 
 
Maximal levels of calcium result in a 60% rise in MLC phosphorylation that falls to 
baseline levels within the next 5-10 minutes (Kamm and Stull, 1985).  After peak levels 
of calcium and MLC phosphorylation start to diminish, a fast-phase in tension generation 
occurs with a high degree of shortening (Figure 1).  The fast-phase of contraction 
typically lasts for 5-10 minutes which correlates with the signals derived from 
intracellular calcium and MLC phosphorylation.  However, smooth muscle tension will 
continue to rise slowly and reach a plateau phase (slow-phase of contraction) whereas the 
calcium levels will decrease along with MLC phosphorylation.  The phorbol ester-
induced contraction displays only the slow-phase of contraction and there is also limited 
calcium influx and MLC phosphorylation (Singer and Baker, 1987).  In a study by 
Wright and Hurn (1994), cytochalasin D, a potent inhibitor of actin polymerization, 
Degree of shortening 
[Ca2+]i 
500nM
50nM
60% 
Time (mins.) 
High Low
 
Slow-phase 
Fast-phase 
MLC-P
shortening
Tension
Ca2+ 
MLC(20)P 
Total MLC 
 
        3.5 
 
Tension (g) 
K+ 5   10      20     30     40      50
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significantly decreased the slow-phase of the potassium contraction, however did not 
disrupt the fast-phase.  In regards to phorbol esters, cytochalasin D also disrupted 
contraction (Wright and Hurn, 1994).  These results suggest that actin polymerization is 
necessary for the slow-phase of smooth muscle contraction.  This form of actin 
remodeling may explain why smooth muscle has a longer plateau in regards to the length-
tension relationship in comparison to skeletal muscle.  Furthermore, actin-binding 
proteins, such as MLCK, may influence this remodeling phenomenon. 
Podosomes 
The actin/myosin cytoskeleton of contracting A7r5 smooth muscle cells 
reorganizes into podosomes (Fultz and Wright, 2003).  Podosomes are adhesive 
structures that are rich in actin and actin-binding proteins.  These proteins are surrounded 
by a ring of myosin and create a column-like structure that is arranged in a rosette 
configuration within the cell (Figure 2).  
 
Figure 2.  Actin isoform distribution and remodeling in the A7r5 smooth muscle cell.  
Note that the α-actin remodels into podosomes in a rosette fashion in the periphery of the 
cell.  β-Actin stays in filaments after PDBu stimulation at 10-7M concentration and 
remodels into podosomes at 10-5M concentration.  A23187 is a calcium ionophore that 
contracts A7r5 cells without forming podosomes.   
 
α-actin = green 
β-actin = red 
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Although it was earlier proposed that podosomes represent contractile structures in A7r5 
cells, it has recently been suggested that these podosomes may be invasive structures 
subsequently referred to as invadopodia (Burgstaller and Gimona, 2005, Gimona and 
Buccione, 2006).  Cells are most commonly grown on glass coverslips for imaging and 
this may not be an optimal condition for understanding smooth muscle cytoskeletal 
remodeling and contraction.  Cells in the vasculature are surrounded by an extracellular 
matrix (ECM) and are arranged in an interconnected fashion with connecting gap 
junctions.  In a study by Burgstaller and Gimona (2005), A7r5 cells were grown on 
fluorescently labeled fibronectin and podosomes were found to degrade this substrate.  
Matrix metalloproteinases (MMPs) are proteins responsible for degrading the 
extracellular matrix and MMPs are kept inactive through binding with tissue inhibitors of 
matrix metalloproteinases (TIMPs).  Once this interaction is abolished, then MMPs can 
become activated and degrade the ECM.  Smooth muscle cells contain MMP-2,  -9, and -
14 and these MMPs can degrade Type I, III, IV, V, VII, X, XI collagens, elastin, α-
casein, gelatin, fibronectin, and other ECM proteins (Woessner and Nagase, 2000).  It 
will be of interest to see if MMPs are located within the podosome and if inhibition of 
MMPs prevents the formation of podosomes (please refer to section VI for further 
evaluation).  Whether or not podosomes represent focal adhesions or ECM degrading 
structures, podosomes contain the actin-myosin complex (Fultz and Wright, 2003) and 
show the presence of phosphorylated MLCs (Figure 15).  The actin-myosin interaction 
and phoshorylation of MLCs are both necessary for smooth muscle contraction and 
migration. 
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 An interesting difference between skeletal muscle and smooth muscle is that 
smooth muscle requires MLC phosphorylation in order to create force.  The main site 
phosphorylated on MLC is a serine residue at position 19 of the protein.  MLC 
phosphorylation typically increases within the first two minutes of exposure to the 
agonist and then precipitously starts to fall down to baseline levels (Figure 1).  Despite 
this reduction in MLC phosphorylation, smooth muscle tension remains high.  
Explanations of how this occurs are still lacking at this time.  Phorbol esters are 
responsible for activating PKCα and this initiates two signaling pathways.  First, PKCα 
activates CPI-17 which inhibits myosin light chain phosphatase (MLCP) (Somlyo and 
Somlyo, 2003).  This allows for the MLCs to remain in the phosphorylated state.  
Second, PKC may phosphorylate MLCs at serines 1,2 and threonine 9 (Stull et al., 1996).  
This causes an inhibition of MLCK phosphorylation of the light chains at serine 19.  
PKCα activation does not create a rise in MLC phosphorylation to the extent of 
potassium depolarization in swine carotid arteries (Singer, 1990).  In uterine smooth 
muscle, oxytocin activates PKC with a resultant increase in contraction without an 
increase in RLC phosphorylation or [Ca2+]I levels (Oishi et al., 1991).  This phenomenon 
has been referred to as calcium sensitization because the contractile apparatus appears to 
be highly sensitive to small fluxes in calcium (Somlyo and Somlyo, 2003).  Whether or 
not calcium sensitization, the latch hypothesis, or actin remodeling is the primary 
mechanism underlying smooth muscle contraction is still in question.  Here we evaluate 
smooth muscle contraction in regards to MLCK activation in the phorbol ester-stimulated 
A7r5 cell and rat aortae.            
III.  Kinase properties of MLCK 
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MLCK can be classified as a multi-functional protein with a primary function to 
phosphorylate the serine-19 residue of the MLCs of myosin.  The phosphorylation of 
MLCs activates the myosin ATPase which allows the power stroke to occur.  In order for 
actin-myosin interaction to occur, the myosin binding site on actin must be available.  
Also, the distance between the two filamentous proteins must be exact in order for the 
appropriate sliding mechanism to be realized.  If the filaments are too far away from each 
other there will be no interaction.  Conversely, if the filaments are too close to one 
another, then tension generation is not optimal.  MLCK-actin binding properties suggest 
an attractive coupling mechanism, because MLCK could regulate actin-myosin 
interaction through non-kinase properties not related to its kinase domain.  It should be 
noted that caldesmon and calponin also regulate actin-myosin interaction, but neither 
protein has been characterized to have a kinase domain for phosphorylating the light 
chains of myosin.   
 MLCK can undergo autoregulation.  The protein conformation of MLCK is such 
that a portion of the kinase is hidden by the autoregulatory segment located upstream 
from the kinase domain (pseudosubstrate region) (Stull et al., 1998).  When activated, 
CaM binds to this region causing MLCK to undergo a conformational change, exposing 
the kinase domain and activating the enzyme.  A plethora of protein kinases can 
phosphorylate portions of the kinase domain and C-terminal sequence of MLCK which 
increases the KCaM (equilibrium constant of CaM) (Stull et al., 1997).  This results in an 
increased requirement of activated CaM.  Clusters of phosphoamino residues in the 
MLCK protein have been described and differences in the site of phosphorylation have 
been reported by different sources (Vorotnikov et al., 2002) (Table 1).  Inhibition of 
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MLCK has been found in the Ca2+/CaM binding region (aa. 787-815) and has been called 
“site A.”  The N-terminal region of the kinase-related protein (KRP) domain of MLCK 
has been called “site B” (~ aa. 828).  Typically, site A phosphorylation can be blocked 
via binding of Ca2+/CaM, however this is not absolute (Table 1). 
 
Table 1.  Protein phosphorylation effects on MLCK kinase domain (Vorotnikov et al., 
2002) 
Source of MLCK Enzyme 
responsible for 
phosphorylating 
MLCK 
Site A Site B Inhibition of 
phosphorylation 
through Ca2+/CaM 
binding 
Avian PKA + + Site A 
Sheep 
myometrium 
PKA + + Neither site 
Bovine PKG - + Site B 
Human platelet PKG - residue 
distinct 
from Site A 
+ Site B 
Human platelet PKC - + Site B 
Endothelial cells PAK   Ser-991, unique site 
on MLCK (does 
inhibit) 
 
Site A phosphorylation inhibits the ability for MLCK to phosphorylate the MLC and thus 
prevents activation of the myosin ATPase.  This form of regulation is thought to play a 
secondary role in the relaxation of smooth muscle.  The primary mechanism is through 
expulsion of Ca2+ from the cytosol via Na+/Ca2+ exchangers and/or Ca2+-ATPase pumps 
(Stull et al., 1997). 
The effect of site B phosphorylation remains unclear as to function in smooth 
muscle.  It is thought that site B phosphorylation may affect MLCK binding to myosin as 
well as cause the inhibition of myosin phosphorylation.  MLCK also has the ability to 
phosphorylate itself (Kamm and Stull, 1985).  MLCK’s autophosphorylation sites lie 
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within its kinase domain and in the N-terminal region of the protein.  It is thought that 
autophosphorylation plays a role in MLCK activation; however, the in vitro data do not 
correlate well with in vivo data (Stull et al., 1996).  In the future it will be of interest to 
understand how protein kinase phosphorylation of MLCK affects its catalytic activity in 
smooth muscle. 
IV.  Non-kinase properties of MLCK 
 
 In order to understand the non-kinase properties of MLCK, it is imperative to 
understand the techniques we and others have employed to study MLCK-actomyosin 
interactions.  Typically, MLCK’s tendency to degrade and its lower abundance than actin 
or myosin in smooth muscle make it a difficult protein to purify.  Chicken or turkey 
gizzard supplies the most MLCK per gram of soft tissue and this still may only yield 
milligrams of intact MLCK (Adelstein and Klee, 1982).  Actin and myosin are easier to 
purify although smooth muscle myosin ATPase activity can be reduced quite 
dramatically in the purification process (Adelstein and Sellers, 1996). 
 MLCK’s ability to bind to actin was first demonstrated through centrifugation 
procedures (Hayakawa et al., 1999a).  Actin, by itself, will not precipitate at low levels of 
centrifugation (≤ 11,000 g) and it is only after MLCK is added to the actin solution that a 
pellet will form after centrifugation.  This is due to MLCK’s ability to crosslink and 
bundle actin filaments (Kohama et al., 1996).  As MLCK concentration increases, more 
actin bundles will form up to a saturated concentration (Hayakawa et al., 1999b).  It has 
also been found that when Ca2+/CaM is added to the solution, MLCK cannot bundle actin 
as effectively and more MLCK appears in the supernatant as opposed to the pellet when 
analyzed by gel electrophoresis (Hayakawa et al., 1994).  MLCK appears to have two 
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types of actin-binding sites; one is a Ca2+/CaM-sensitive site and the other is a Ca2+/CaM- 
insensitive site.  It is also interesting to note that MLCK has a higher binding affinity for 
purified myofilaments than to F-actin alone (Stull et al., 1998).  This suggests that 
another protein contaminant may facilitate binding of MLCK on purified myofilaments 
that is absent on F-actin polymerized de novo (Stull et al., 1998). 
 In order to understand where these sites are located in the MLCK protein, MLCK 
was subjected to cyanogen bromide (CNBr) which cleaves proteins at methonine (Met) 
residues and 2-nitro-5-thiocyanobenzoic acid (NTCB) which cleaves at cysteine  residues 
(Gao et al., 2001).  After cleavage, the CNBr created an aspartate (Asp)2-Met213 fragment 
of MLCK that contained both Ca2+/CaM-sensitive and -insensitive sites (Gao et al., 
2001).  NTCB created a fragment of Met1-lysine(Lys)114 which was found to only contain 
the Ca2+/CaM-sensitive site (Gao et al., 2001).  The MLCK/actin-binding studies showed 
that the NTCB fragment was unable to bundle actin filaments and its binding activity was 
totally abolished by the Ca2+/CaM complex.  Because binding and bundling are two 
separate activities, the results further indicated at least two distinct binding sites.  
Bundling requires the presence of both Ca2+/CaM-insensitive and -sensitive sites whereas 
binding requires the presence of only one actin-binding site.  In this case, only the 
Ca2+/CaM-insensitive site showed binding to actin filaments in the presence of the 
Ca2+/CaM complex (Gao et al., 2001). 
 In order to get a more precise location of the actin binding sites, recombinant 
peptide fragments and site-directed mutagenesis were performed.  Smith et al. (1999), 
reported that by deleting the first twenty-three amino acids of MLCK, 50% of the protein 
remained in the supernatant and did not bind to myofilaments.  When they deleted the 
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first 39 or 58 amino acids from the N-terminal region, no significant binding occurred.  
This indicated that amino acid region 24-39 or 24-58 contained a significant actin binding 
structure (Smith et al., 1999).  In a study by Ye et al. (1997), E. coli recombinant protein 
fragments were used to show that as the NN-fragment (aa. 1-526) concentration 
increased, more of the fragment was able to bind to actin (the NN-fragment contains both 
Ca2+/CaM-sensitive and -insensitive sites).  This binding was significantly affected when 
the Ca2+/CaM-sensitive sites were deleted (NC-fragment).  When the first 41 amino acids 
of the NN-fragment were deleted, a more significant decrease in actin-binding was seen 
in comparison to the NC-fragment.  Also Ye et al. (1997) showed that the 1-41 peptide 
competitively inhibited the binding of the NN-fragment to actin.  Therefore, it was 
concluded that the 1-41 amino acid sequence of MLCK contained the actin-binding core. 
 Once comparative sequence analysis was performed on the first seventy-five 
amino acids of MLCK, it was found that sequences were almost identical among various 
vertebrate species (Smith et al., 1999).  To evaluate the key elements of this sequence, 
alanine substitutions were made at various points in the N-terminus of MLCK.  Out of 10 
substitutions that were made, peptides with alanines substituted at aspartate Asp-30 (D), 
phenylalanine (Phe)-31 (F), arginine (Arg)-32 (R), and leucine (Leu)-35 (L) showed 
decreased binding affinity for actin filaments.  This sequence, called the DFRXXL motif, 
was found at 3 locations in the N-terminus of MLCK.  One location is at residues 2-7, 
another is at 30-35, and the last motif is located at 58-63 (Smith et al., 1999).  When D, F, 
and R were replaced with triple alanines, all three motifs were found to at least be partly 
involved in binding to actin.  Residues 2-4 showed 47% of pellet left, 30-32 showed 57% 
of pellet left, and 58-60 showed 34% of pellet left (Smith et al., 1999).   
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 Consequently, after identification of the actin-binding core, CaM-binding regions 
within the first 114 amino acids were studied by a process called surface plasmon 
resonance.  Surface plasmon resonance is a process where a cuvette coated with CaM-
dansyl has a fluorescence at 518 nm.  Once a protein or Ca2+ ions binds to this 
compound, the intensity increases and the spectrum shifts to a shorter wavelength (470 
nm).  Treatment with MLCK and calcium in the presence of this CaM derivative caused a 
large, upward shift in fluorescence (Hayakawa et al., 1999b).  Due to the fact MLCK 
contains two CAM-binding regions; one at the actin binding domain and one in its kinase 
domain, the N-terminus was further evaluated in the absence of the kinase domain.  The 
fluorescent shift of the N-fragment and the 25/NN-fragment (1-25 aa. were missing) had 
a similar shift in fluorescence (Hayakawa et al., 1999b).  The 41/NN-fragment did not 
bind to CAM and did not cause an upward shift in fluorescence (Hayakawa et al., 1999b).  
Upon synthesis of a 26-41 peptide and notation of an upward shift in fluorescence, it was 
concluded that this region contained the CaM-binding sensitive site (Figure 3).   
Figure 3.  Molecular anatomy of MLCK.  Redrawn from Molecular Mechanisms of 
Smooth Muscle Contraction, Chapter 2, Hayakawa et al., 1999b.  Actin-binding regions 
are blue, the myosin-binding site is red, CaM-binding sites are green, and actin-binding 
amino acid residues are depicted in pink.  
 
NH2 COOHTelokinKinase
CaM-binding site
26- 41
CaM-binding site
796- 815
MYOSINACTIN ACTIN
•MDFRANLQRQ  VKPKTLSEEE RKVHG (26) PQQVDFRSVLAKKGTP(41)
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The C-terminal region of MLCK is also an area of intense research.  The C-
terminus of the MLCK gene has its own promoter within an intron of the DNA and can 
produce its own transcript forming a protein named KRP (kinase-related protein) or 
telokin (“telos” of the kinase).  KRP weighs 17.7 kDa and was originally discovered as a 
by-product in the purification of calmodulin (Vorotnikov et al., 2002).  KRP can bind to 
myosin keeping it in filamentous form (Shirinsky et al., 1993).  This is thought to keep 
the contractile apparatus structured in resting cells.  Although it keeps myosin structured, 
it does not affect MLC phosphorylation.  In fact, KRP is noted for having a higher 
binding affinity for unphosphorylated myosin as opposed to the phosphorylated form 
(Stull et al., 1998).  An interesting study by Gao et al. (2003) showed that a slightly larger 
fragment of the C-terminus of MLCK did play a role in enhancing the myosin ATPase 
activity without phosphorylation of the MLCs.  Some groups suggest that KRP may be 
responsible for the dephosphorylation of myosin, since KRP applied to “chemically 
skinned” smooth muscle shows a relaxation effect (Krymsky et al., 2001).  It is thought 
that this relaxation effect works via MLCP (Krymsky et al., 2001).  Upon increases in 
KRP phosphorylation, MLCP activity will increase allowing MLC phosphorylation to 
decrease and contraction will subside.  There are three identified sites in KRP that can 
become phosphorylated by protein kinases:  serines 12, 15, 18 (Krymsky et al., 2001) 
(Serine 12 is the same as “site B” on the intact MLCK molecule).  Protein kinases A/G 
can phosphorylate Ser 12, in vitro, while mitogen-activated protein kinase (MAPK) and 
glycogen synthase kinase-3 (GSK3) can phosphorylate Ser 18 and 15, respectively 
(Krymsky et al., 2001).  It is also thought that the phosphorylation is ordered, that Ser 18 
phosphorylation of MAPK will precede GSK3 phosphorylation of Ser 15.  Despite the 
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complexity of KRP phosphorylation, one interesting fact is that phorbol esters (PDBu) 
will increase the level of KRP phosphorylation (Krymsky, et al., 2001).  In the study by 
Krymsky et al. (2001), it was noted that KRP phosphorylation increases 25-40% of its 
resting value in carotid arteries.  Although KRP levels go up, there is no change in the 
contractility of the tissue.  It has been established that PKC can inhibit MLCP through 
CPI-17 (Somlyo and Somlyo, 2003).  Whether or not KRP phosphorylation and PKC 
activation play additive roles with smooth muscle contraction remains a mystery. 
 Not only does MLCK have multiple functions, it has been shown that multiple 
isoforms exist for MLCK.  One isoform, referred to as the long- or 220-kDa isoform of 
MLCK, is a protein expressed ubiquitously during embryonic development (Blue et al., 
2002).  It is identical to the short or 130-kDa isoform of MLCK, except that it has a long 
N-terminal extension of 955 amino acids (Gao et al., 2001).  The 130-kDa isoform of 
MLCK is the adult form that is found in smooth muscle; however, even in adulthood the 
220-kDa isoform is found in lung, kidney, liver, vas deferens, and bladder (Blue et al., 
2002).  In cell lines such as A10 or A7r5, both isoforms can be found (Poperechnaya et 
al., 2000).  In nonmuscle cell lines, such as HeLa or PtK2, only the long isoform exists 
(Poperechnaya et al., 2000).  Localization of the 130-kDa isoform is found in the 
perinuclear area with some stress fiber localization (Lin et al., 1999).  The 220-kDa 
isoform however, is strictly located on the stress fiber and can be found in the cell cortex 
and cleavage furrow of dividing cells.  Recently, it has been discovered that the 220-kDa 
isoform also has a microtubule-binding domain (MTBD) located in the N-terminal 
extension.  This MTBD structure has lower affinity sites for actin in comparison to the 
DFRXXL motif and can influence the bundling, branching, and polymerization of tubulin 
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(Kudryashov et al., 2004).  Actin and microtubules are important in mitosis and cell 
spreading and movement and it is thought that the 220-kDa isoform may be responsible 
for integrating the microtubule and actin filament networks (Kudryashov et al., 2004).  
The 220-kDa isoform of MLCK contains 2 additional DFRXXL motifs in comparison to 
the 130-kDa isoform.  These additional DFRXXL motifs are thought to confer a higher 
affinity for actin than the smaller isoform of MLCK (Smith et al., 2002). 
 In the paper by Hatch et al. (2001), the first 147 amino acids of MLCK were 
sequenced and 3-D reconstructions on the actin filament were evaluated.  From 3-D 
reconstructions, MLCK complexed with F-actin showed an increase in axial diameter 
compared to F-actin alone.  When these data were fitted to molecular models of actin, it 
was found that MLCK attached to the C-terminal residues of subdomain-1 of one actin 
monomer and formed a bridge to the second actin monomer at residues 228-232, an 
alpha-helix in subdomain-4.  One interesting note is that MLCK by itself is largely 
unstructured; however, when placed with F-actin it assumes a compact shape (Hatch et 
al., 2001).  In comparison to other actin-binding proteins, such as calponin and 
caldesmon, MLCK binds to a unique position on the actin molecule (Hatch et al., 2001).  
This would be expected to prevent competition between MLCK and other proteins and 
allow MLCK to stably interact with actin.  Neutron scattering data has been collected on 
the catalytic and autoinhibitory domains of skeletal MLCK complexed with CaM, MLC, 
and an ATP analog.  In the presence of these protein partners, the centers of mass of CaM 
and MLCK come closer together.  This compaction between CaM and MLCK is similar 
to the compaction between PKA and ATP binding (Stull et al., 1998).  MLCK also 
contains fibronectin-like and three Ig-like structural motifs (Stull et al., 1998).  These 
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motifs consist of about 100 amino acids and can be found in such proteins as titin and 
elastin (Stull et al., 1998).  Stull et al. (1998) note that these motifs are typically found in 
elastic compounds and may provide resistance to passive tension development.  It is 
thought that CaM binds to an area downstream of the catalytic domain, collapses, and 
moves down the autoregulatory segment to remove autoinhibition (Stull et al., 1998).  
Removal of the first 8 amino acid residues of CaM can reduce maximal activity of 
MLCK by 50%.  Stull et al. (1998) further note that although activation of MLCK was 
changed, the binding affinities for these mutants were not different from the wild-type 
phenotype.  Therefore, the N-terminus of CaM is important for activation but not for 
binding to the MLCK molecule.  Not only can MLCK be found on the actin filament, but 
it has been localized to the nuclear matrix (Simmen et al., 1984).  In chicken liver 
extracts, estrogen stimulation caused an increase in CaM and MLCK localization at the 
nuclear matrix (Simmen et al., 1984).  MLCK has also been found in the nucleoli of PtK2 
and CHO cell lines (Guerriero et al., 1981).  In the N-terminus of mammalian MLCKs, a 
12 residue repeat motif was found with an internal KP(A/V) sequence that may be 
responsible for chromatin binding (Gallagher et al., 1991).  This KP(A/V) sequence has 
also been found in histone H1 and neurofilament proteins M and H (Gallagher et al., 
1991).  Neurofilament proteins are known to bind to single-stranded DNA.   
 The transcription of the MLCK gene is quite complex and recently some 
information on its regulation has come to light.  The 220 and 130-kDa isoforms use the 
same promoter with an internal promoter located within exon 29 for KRP expression 
(Birukov et al., 1998).  The promoter region of the MLCK gene contains a CAG box 
which allows serum response factor (SRF) to bind and increase expression of MLCK 
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(Han et al., 2006).  It has been noted that the CAG box is found with other muscle 
specific genes, such as MHC, and that modulation of this promoter site could affect the 
contractile apparatus.  In the spontaneously hypertensive rat (SHR) model, it has been 
shown that the CAG box has a string of 12 CT nucleotides (nts) that enhances the binding 
of SRF to the MLCK promoter (Han et al., 2006).  Results from this study suggest that 
increased expression of MLCK causes a concomitant increase in blood pressure in the 
SHR rat.  These results suggest that MLCK expression at the mRNA level initiates 
hypertension and could be a possible factor in idiopathic hypertensive cases in humans. 
 
V.  FRET and Confocal Imaging 
 
 Fluorescence Resonance Energy Transfer (FRET) is the nonradiative process of 
energy donation from one fluorophore to a nearby accepting fluorophore.  Typically, 
FRET occurs at a spatial distance of 1-10 nanometers (nm) and is used to detect 
conformational changes of proteins (Kenworthy, 2001).  Confocal microscopy is the 
process of using specific wavelengths of light to excite certain fluorophores and by using 
a pinhole aperture in front of the light detector, confocal rejects certain light diffraction 
and only accepts light that passes directly through the aperture.  This improves spatial 
resolution by eliminating all out-of-focus light that is above and below the focal plane.  
Spatial resolution of most confocal microscopes is in the range of 200-500 nm and 
improvement on this resolution can be achieved through FRET protocols (Kenworthy, 
2001).  One protocol is a process called acceptor photobleaching.  Acceptor 
photobleaching is the photodestruction of the acceptor fluorophore so that it can no long 
accept energy from a nearby donor fluorophore. 
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 In order for FRET to occur certain criteria must be met.  One, the emission 
spectrum of the donor must overlap the excitation spectra of the acceptor.  There are 
numerous donor and acceptor pairs and some of these are listed in Table 2.   
Table 2.  Donor and acceptor pairs for FRET analysis 
Donor 
fluor 
Acceptor 
fluor 
Type of experiment (photobleaching, 
sensitized emission, etc.) 
Reference 
FITC TRITC  Sensitized emission (Dictenberg et al., 
1998) 
FITC TMR Acceptor photobleaching (Chhabra and dos 
Remedios, 2005) 
FITC Rhodamine Gradual acceptor photobleaching (Kam et al., 1995) 
Alexa488 Alexa555 Sensitized emission (Chen et al., 2003) 
 
Second, the dipoles of the fluorophores must be oriented parallel to one another.  This is 
to insure energy transfer does not under- or overshoot the acceptor fluorophore.  Finally, 
distance between the two fluorophores must be small in order for FRET to occur (1-10 
nm).  There are numerous indices one can use to measure FRET and one of the most 
common is transfer efficiency.  Transfer efficiency is E= 1- (ID/IDNA), where E represents 
transfer efficiency, ID is the intensity of the donor in the presence of the acceptor and IDNA 
is the intensity of the donor with no acceptor (Kenworthy, 2001).  Forster distance is an 
index used to define the angstrom distance when energy transfer is 50%.  In these studies, 
transfer efficiency or some deviation of this equation is used since the Forster distance 
requires some assumptions about the given system employed (e.g. dipole orientation). 
 FRET can be applied to various microscope setups.  Wide-field microscopy is 
used to measure FRET and advantageous for multiple fluorophores using various 
excitation filters compared to conventional laser-scanning confocal microscopes.  It has 
also been reported that charged-coupled cooled devices (CCDs) have greater sensitivities 
than photomultipler tubes (PMTs) (Kenworthy, 2001).  A disadvantage of wide-field 
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scopes is the long time needed in order to photobleach an acceptor fluorophore.  Also, 
wide-field scopes do not provide targeted regions for photobleaching.  Therefore, the 
entire viewing area must be photobleached.  Confocal microscopes provide the ability to 
change the intensity of the laser power which allows for a reduction in photobleaching 
time constants.  It can also target regions of interest inside of a cell or organelle that can 
be used to provide an internal control (Kenworthy, 2001).  Typically, when 
photobeaching a region of interest, only that area will show a FRET effect while areas 
outside will show no response.  In all cases, it is important to generate controls for 
evaluation of the FRET response.  Positive controls may include evaluation of proteins 
that have a distance less than 10 nm.  This is done by targeting a primary antibody with 
secondary antibodies that have both donor and acceptor fluorophores (Chen et al., 2003).  
In a similar vein, negative controls can be employed through the analysis of 
protein/protein interaction where no interaction should occur.  This might be to label a 
membrane protein and a cytosolic protein when studying the interaction between two 
cytosolic proteins (Chen et al., 2003).  There should also be single labeled specimens that 
have either donor-only or acceptor-only labels.  This is used to confirm that signal 
bleedthrough or back bleedthrough does not occur in a given system (Chen et al., 2003).  
These controls will help define the type of interaction that is occurring with donor- and 
acceptor-labeled samples.   
Recently, FRET has been employed to study the catalytic domain of MLCK 
(Isotani et al., 2004).  CFP and YFP proteins were flanked on either side of the Ca2+/CaM 
domain near the kinase site.  FRET would be highest in the absence of CaM binding and 
lowest when the CaM binds to the regulatory region of MLCK.  Isotani et al. (2004) 
 24
studied permeabilized smooth muscle bladder strips under KCl (high Ca2+ conditions) and 
carbachol (low Ca2+ conditions) situations.  They found that MLCK exhibited an initial 
20% increase in activation which then slowly declined.  Carbachol caused a smaller 
increase in activation (~10%) which also declined with time.  Despite the fact that 
calcium levels, MLC phosphorylation, and force were at maximal levels, MLCK was 
never fully activated.  The authors conclude that this was due to limited amounts of CaM 
since CaM binds to other proteins (calponin and caldesmon) besides MLCK (Isotani et 
al., 2004).  Together, the results suggest that a coordinated response between MLCK 
activation and inhibition of MLCP must be inherent in smooth muscle cells in view of 
such high levels of MLC phosphorylation and force development. 
 In summary, although MLCK is widely recognized as a central protein in smooth 
muscle contraction, the bulk of research interest has focused on its kinase properties.  The 
present studies are focused on the N-terminal region of MLCK and its interaction with 
myosin and actin isoforms as they may contribute to force development.  Here we 
examined this interaction in the A7r5 smooth muscle cell line and rat aorta using FRET 
analysis and confocal microscopy.  
VI.  Podosomes and Invadopodia 
 
 It has been recently discovered that smooth muscle cells also contain actin rich 
structures referred to as podosomes (Brandt et al., 2002, Burgstaller and Gimona, 2004, 
Fultz et al., 2000, Hai et al., 2002, Kaverina et al., 2003, Linder and Aepfelbacher, 2003, 
Linder and Kopp, 2005).  Podosomes contain a number of actin-binding proteins and can 
be activated by the protein kinase C (PKCα) signaling system in smooth muscle (Hai et 
al., 2002).  The A7r5 cell line, an embryonic thoracic aorta cell, expresses many of the 
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smooth muscle markers found in differentiated smooth muscle (Firulli et al., 1998) and is 
recognized as a good model for the study of vascular smooth muscle.  The A7r5 cell uses 
a PKCα signal that activates c-Src, a non-receptor tyrosine kinase (Brandt et al., 2002).  
Activation of c-Src then increases the activity of p190RhoGAP, a GTPase protein, that 
will result in decreased activity of RhoA (Brandt et al., 2002).  These signaling schemes 
indicate that both serine/threonine phosphorylation via PKCα or MLCK and tyrosine 
phosphorylation via c-Src and focal adhesion kinase (FAK) are important for cell 
contraction with podosome initiation and development.  Interestingly, endothelial cells 
require PKCα, PKCδ, and cyclin-dependent kinase-42 (cdc42) to initiate podosome 
development (Moreau et al., 2006, Tatin et al., 2006, Varon et al., 2006a, Varon et al., 
2006b). 
 Structurally, podosomes are columns of actin surrounded by a ring of myosin and 
vinculin (Fultz and Wright, 2003).  They protrude into the cytosol and cause an upward 
membrane invagination that contains the β1 integrin family of proteins (Linder and 
Aepfelbacher, 2003, Linder and Kopp, 2005).  Cancer cells contain similar structures that 
are used in cell migration and are referred to as invadopodia (Bowden et al., 1999, 
Bowden et al., 2001, Bowden et al., 2006, Mueller and Chen, 1991, Mueller et al., 1992).  
Invadopodia also require tyrosine phosphorylation, p190RhoGAP activation, and are 
filled with actin surrounded by a myosin ring.  According to Artym et al., one difference 
between invadopodia and podosomes is that invadopodia do not contain a ring of vinculin 
(2006).  Some other differences between invadopodia and podosomes are that podosomes 
are dynamic, forming in 2-10 minutes and then undergoing disassembly (Gimona and 
Buccione, 2006).  Invadopodia typically form and last for 2-12 hours.  Invadopodia also 
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form in juxtaposition to the Golgi apparatus whereas podosomes do not (Gimona and 
Buccione, 2006).  Podosome configuration is significantly different between cell types.  
For example, osteoclasts and macrophages form podosomes throughout the cell body 
whereas smooth muscle podosomes form in the lamella close to adhesion spots (Linder 
and Aepfelbacher, 2003, Linder and Kopp, 2005).  Typically, adhesion spots are found in 
the protruding lamellae away from recruitment of the Arp2/3 complex found associated 
with the podosome (Gimona and Buccione, 2006).  In endothelial cells, podosomes form 
in a rosette pattern in the perinuclear region of the cell (Moreau et al., 2003).  Both 
invadopodia and podosomes contain MMPs that degrade the extracellular matrix and 
allow for increased cell motility.  There are 28 different MMP isoforms and certain cell 
types will express certain ones.  In smooth muscle, MMP-2, -9, and MT1-MMP 
(membrane type 1, also known as MMP-14) are found to degrade the ECM.  MMP-14 is 
confined to the membrane and MMP-2 and -9 are cytosolic proteins.  Differences in 
localization are probably due to a signaling cascade; for instance, MMP-14 is thought to 
activate MMP-2 which then activates MMP-9 in smooth muscle (Woessner and Nagase, 
2000).  It is still uncertain how prominent a role the MMPs play in podosome formation 
since there are numerous other proteinases found in cells (e.g. lysosomal and endosomal).  
MMPs are kept in check by TIMPs and to date there are four known isoforms (TIMP1-4).  
Of these compounds, TIMP binding is MMP specific.  TIMP-1 will bind to MMP-9 
whereas TIMP-2 will bind to MMP-2 (Woessner and Nagase, 2000).  MMPs require a 
zinc atom and cleavage of the propeptide sequence for activation.  However, TIMPs can 
bind to both inactive and active forms of MMPs and this may indicate that MMPs are 
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needed for focal spots of degradation as opposed to a widely dispersed secretion of 
proteinases typically seen in the stomach and gastrointestinal tract.   
 MMP activation can occur through multiple pathways.  One pathway is through 
formation of reactive oxygen species.  Phorbol esters have been found to induce ROS in 
human and rabbit SMCs through activation of the PKC signaling system (Mietus-Snyder 
et al., 1997).  This ROS accumulation occurs within the first 5 minutes of phorbol 
stimulation and increases transcription of the scavenger receptor found in smooth muscle.  
This receptor helps SMCs internalize oxidized lipoprotein and cause the development of 
foam cells.  These receptors are found in macrophages as well and are thought to play a 
significant role in the development of atherosclerosis.  Other types of ROS agonists 
include H2O2 and vanadate.  Vanadate inhibits tyrosine phosphatases in cells resulting in 
increased levels of tyrosine phosphorylation (Mietus-Snyder et al., 1997).  Whether or 
not phorbol esters initiate ROS accumulation in the A7r5 cell line is still not known at 
this time. 
 One way to study cell interaction with the substrate is through the development of 
collagen matrices in cell culture systems.  At high collagen concentrations, collagen gels 
will solidify and provide a scaffold onto which cells can spread.  This allows cells to 
become encased within an extracellular environment that is similar to smooth muscle 
cells in vivo.  Cells will then remodel the collagen matrix and form focal adhesions (Song 
et al., 2000, Song et al., 2001).  Recently, it has been suggested that SMCs send guidance 
and contact cues to other SMCs in order to develop interconnections.  Netrin-1 is one of 
these cues that works through the ERK1/2-eNOS pathway via a feed-forward mechanism 
(Nguyen and Cai, 2006).  Depending on the cell density used in developing collagen 
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matrices, experiments can be performed to study cell-matrix or cell-cell interactions and 
the signaling required for this interaction (Grinnell et al., 2003).  In a study by Tamariz et 
al. (2002), low cell density (105 cells/mL) remodeled the collagen matrix differently than 
high cell density (106 cells/mL).  The authors attribute this to the resistance developed 
within the collagen matrix and the formation of focal adhesions.  Focal adhesions provide 
a link between the extracellular environment and the internal cytoskeleton of a cell.  
These focal adhesions then transmit tension generation to the cytoskeleton which results 
in the formation of actin stress fibers (Tamariz and Grinnell, 2002).  High density gels are 
typically studied for matrix contraction and the Rho-kinase and MLCK signaling 
pathways are involved in contraction with bovine aortic smooth muscle cells (Song et al., 
2003).  The group also noted that calcium signals for cell contraction come from the 
intracellular cytosol as opposed to the extracellular space (Song et al., 2003).  The 
authors noted that the actin polymerization machinery (WASP/cdc42) was involved in 
smooth muscle migration, but not matrix contraction.  Our lab has noted that PDBu also 
induces matrix contraction in A7r5 cells, however calcium ionophores have not been 
studied to this point (unpublished observations).  Collagen matrix contraction is the 
decrease in area occupied by both cells and collagen when a contractile stimulus has been 
given.  Within a collagen matrix, PDBu-stimulated A7r5 cells do display podosomes, but 
these structures appear most abundantly in cells grown on glass coverslips (unpublished 
observations).  A7r5 cell contraction and growth in collagen matrices will be of interest 
to those studying atherosclerosis and aortic aneurysm since SMC migration is a 
distinguishing characteristic of these disease phenotypes. 
VII.  Summary 
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 The smooth muscle contraction has been defined as a slow and robust contraction 
with very little energy costs (Murphy and Rembold, 2005).  The latch theory explains 
these given phenomenon as myosin latched to the actin in the ADP-dependent state with 
little ATP hydrolysis (Murphy et al., 1987).  Latch, however, cannot explain the high 
degree of shortening evident in smooth muscle.  It also cannot explain the differences in 
force development and tension maintenance in smooth muscle with different contractile 
agonists (e.g. PDBu and K+). 
 Actin remodeling through polymerization pathways helps to explain this high 
degree of shortening by either increasing or decreasing the amounts of F-actin needed by 
the SMC (Wright and Hurn, 1994).  Furthermore, actin-binding proteins could help to 
explain differences seen in tension development curves.  PDBu and potassium 
depolarization may signal MLCK, calponin, or caldesmon to interact strongly or weakly 
with the actomyosin complex.  In these experiments, the N-terminus of MLCK and 
interaction with actin was evaluated to better understand the actin-remodeling process.  
While no singular theory may explain smooth muscle contraction, we hope that these 
studies shed more light on actin remodeling and how the MLCK non-kinase domain is 
important in the A7r5 cell and vascular smooth muscle. 
 
 
 
 
 
 
 
 30
References 
Adelstein, R. S. and C. B. Klee.  1982.  Purification of smooth muscle myosin light-chain 
kinase.  Methods Enzymol.  85 Pt B(298-308). 
Adelstein, R. S. and J. R. Sellers.  1996.  Myosin structure and function, Biochemistry of 
smooth muscle contraction.  Academic Press.  1st edition, 3-19. 
Artym, V. V., Y. Zhang, F. Seillier-Moiseiwitsch, K. M. Yamada and S. C. Mueller.  
2006.  Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase 
at invadopodia: defining the stages of invadopodia formation and function.  Cancer Res.  
66(6):  3034-43. 
Babu, G. J., G. J. Pyne, Y. Zhou, C. Okwuchukuasanya, J. E. Brayden, G. Osol, R. J. 
Paul, R. B. Low and M. Periasamy.  2004.  Isoform switching from SM-B to SM-A 
myosin results in decreased contractility and altered expression of thin filament 
regulatory proteins.  Am J Physiol Cell Physiol.  287(3):  C723-9. 
Battistella-Patterson, A. S., S. Wang and G. L. Wright.  1997.  Effect of disruption of the 
cytoskeleton on smooth muscle contraction.  Can J Physiol Pharmacol.  75(12):  1287-
99. 
Birukov, K. G., J. P. Schavocky, V. P. Shirinsky, M. V. Chibalina, L. J. Van Eldik and D. 
M. Watterson.  1998.  Organization of the genetic locus for chicken myosin light chain 
kinase is complex: multiple proteins are encoded and exhibit differential expression and 
localization.  J Cell Biochem.  70(3):  402-13. 
Blue, E. K., Z. M. Goeckeler, Y. Jin, L. Hou, S. A. Dixon, B. P. Herring, R. B. 
Wysolmerski and P. J. Gallagher.  2002.  220- and 130-kDa MLCKs have distinct tissue 
distributions and intracellular localization patterns.  Am J Physiol Cell Physiol.  282(3):  
C451-60. 
Bowden, E. T., M. Barth, D. Thomas, R. I. Glazer and S. C. Mueller.  1999.  An 
invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia 
at sites of extracellular matrix degradation.  Oncogene.  18(31):  4440-9. 
Bowden, E. T., P. J. Coopman and S. C. Mueller.  2001.  Invadopodia: unique methods 
for measurement of extracellular matrix degradation in vitro.  Methods Cell Biol.  
63(613-27. 
Bowden, E. T., E. Onikoyi, R. Slack, A. Myoui, T. Yoneda, K. M. Yamada and S. C. 
Mueller.  2006.  Co-localization of cortactin and phosphotyrosine identifies active 
invadopodia in human breast cancer cells.  Exp Cell Res.  312(8):  1240-53. 
Brandt, D., M. Gimona, M. Hillmann, H. Haller and H. Mischak.  2002.  Protein kinase C 
induces actin reorganization via a Src- and Rho-dependent pathway.  J Biol Chem.  
277(23):  20903-10. 
 31
Burgstaller, G. and M. Gimona.  2004.  Actin cytoskeleton remodelling via local 
inhibition of contractility at discrete microdomains.  J Cell Sci.  117(Pt 2):  223-31. 
Burgstaller, G. and M. Gimona.  2005.  Podosome-mediated matrix resorption and cell 
motility in vascular smooth muscle cells.  Am J Physiol Heart Circ Physiol.  288(6):  
H3001-5. 
Chaponnier, C. and G. Gabbiani.  2004.  Pathological situations characterized by altered 
actin isoform expression.  J Pathol.  204(4):  386-95. 
Chen, Y., J. D. Mills and A. Periasamy.  2003.  Protein localization in living cells and 
tissues using FRET and FLIM.  Differentiation.  71(9-10):  528-41. 
Chhabra, D. and C. G. dos Remedios.  2005.  Cofilin, actin and their complex observed in 
vivo using fluorescence resonance energy transfer.  Biophys J.  89(3):  1902-8. 
Chrzanowska-Wodnicka, M. and K. Burridge.  1996.  Rho-stimulated contractility drives 
the formation of stress fibers and focal adhesions.  J Cell Biol.  133(6):  1403-15. 
Dictenberg, J. B., W. Zimmerman, C. A. Sparks, A. Young, C. Vidair, Y. Zheng, W. 
Carrington, F. S. Fay and S. J. Doxsey.  1998.  Pericentrin and gamma-tubulin form a 
protein complex and are organized into a novel lattice at the centrosome.  J Cell Biol.  
141(1):  163-74. 
dos Remedios, C. G., M. Miki and J. A. Barden.  1987.  Fluorescence resonance energy 
transfer measurements of distances in actin and myosin. A critical evaluation.  J Muscle 
Res Cell Motil.  8(2):  97-117. 
Firulli, A. B., D. Han, L. Kelly-Roloff, V. E. Koteliansky, S. M. Schwartz, E. N. Olson 
and J. M. Miano.  1998.  A comparative molecular analysis of four rat smooth muscle cell 
lines.  In Vitro Cell Dev Biol Anim.  34(3):  217-26. 
Fultz, M. E., C. Li, W. Geng and G. L. Wright.  2000.  Remodeling of the actin 
cytoskeleton in the contracting A7r5 smooth muscle cell.  J Muscle Res Cell Motil.  
21(8):  775-87. 
Fultz, M. E. and G. L. Wright.  2003.  Myosin remodelling in the contracting A7r5 
smooth muscle cell.  Acta Physiol Scand.  177(2):  197-205. 
Gallagher, P. J., B. P. Herring, S. A. Griffin and J. T. Stull.  1991.  Molecular 
characterization of a mammalian smooth muscle myosin light chain kinase.  J Biol Chem.  
266(35):  23936-44. 
Gao, Y., K. Kawano, S. Yoshiyama, H. Kawamichi, X. Wang, A. Nakamura and K. 
Kohama.  2003.  Myosin light chain kinase stimulates smooth muscle myosin ATPase 
activity by binding to the myosin heads without phosphorylating the myosin light chain.  
Biochem Biophys Res Commun.  305(1):  16-21. 
 32
Gao, Y., L. H. Ye, H. Kishi, T. Okagaki, K. Samizo, A. Nakamura and K. Kohama.  
2001.  Myosin light chain kinase as a multifunctional regulatory protein of smooth 
muscle contraction.  IUBMB Life.  51(6):  337-44. 
Gimona, M. and R. Buccione.  2006.  Adhesions that mediate invasion.  Int J Biochem 
Cell Biol.  38(11):  1875-92. 
Gimona, M., I. Kaverina, G. P. Resch, E. Vignal and G. Burgstaller.  2003.  Calponin 
repeats regulate actin filament stability and formation of podosomes in smooth muscle 
cells.  Mol Biol Cell.  14(6):  2482-91. 
Gimona, M. and J. V. Small.  1996.  Calponin, Biochemistry of smooth muscle 
contraction.  Academic Press.  1st edition, 91-101. 
Grinnell, F., C. H. Ho, E. Tamariz, D. J. Lee and G. Skuta.  2003.  Dendritic fibroblasts 
in three-dimensional collagen matrices.  Mol Biol Cell.  14(2):  384-95. 
Guerriero, V., Jr., D. R. Rowley and A. R. Means.  1981.  Production and 
characterization of an antibody to myosin light chain kinase and intracellular localization 
of the enzyme.  Cell.  27(3 Pt 2):  449-58. 
Hai, C. M., P. Hahne, E. O. Harrington and M. Gimona.  2002.  Conventional protein 
kinase C mediates phorbol-dibutyrate-induced cytoskeletal remodeling in a7r5 smooth 
muscle cells.  Exp Cell Res.  280(1):  64-74. 
Han, Y. J., W. Y. Hu, O. Chernaya, N. Antic, L. Gu, M. Gupta, M. Piano and P. de 
Lanerolle.  2006.  Increased myosin light chain kinase expression in hypertension: 
Regulation by serum response factor via an insertion mutation in the promoter.  Mol Biol 
Cell.  17(9):  4039-50. 
Hatch, V., G. Zhi, L. Smith, J. T. Stull, R. Craig and W. Lehman.  2001.  Myosin light 
chain kinase binding to a unique site on F-actin revealed by three-dimensional image 
reconstruction.  J Cell Biol.  154(3):  611-7. 
Hayakawa, K., H. Kishi, K. Kohama, Y. Lin, A. Nakamura, T. Okagaki, Y. Xue and L.-
H. Ye.  1999a.  Molecular mechanisms of smooth muscle contraction, Molecular Biology 
Intelligence Unit 5.  RG Landes Company.  1st editon, 15-25. 
Hayakawa, K., T. Okagaki, L. H. Ye, K. Samizo, S. Higashi-Fujime, T. Takagi and K. 
Kohama.  1999b.  Characterization of the myosin light chain kinase from smooth muscle 
as an actin-binding protein that assembles actin filaments in vitro.  Biochim Biophys Acta.  
1450(1):  12-24. 
Isotani, E., G. Zhi, K. S. Lau, J. Huang, Y. Mizuno, A. Persechini, R. Geguchadze, K. E. 
Kamm and J. T. Stull.  2004.  Real-time evaluation of myosin light chain kinase 
activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse.  Proc 
Natl Acad Sci U S A.  101(16):  6279-84. 
 33
Ito, M., R. Dabrowska, V. Guerriero, Jr. and D. J. Hartshorne.  1989.  Identification in 
turkey gizzard of an acidic protein related to the C-terminal portion of smooth muscle 
myosin light chain kinase.  J Biol Chem.  264(24):  13971-4. 
Kam, Z., T. Volberg and B. Geiger.  1995.  Mapping of adherens junction components 
using microscopic resonance energy transfer imaging.  J Cell Sci.  108 ( Pt 3)(1051-62. 
Kamm, K. E. and J. T. Stull.  1985.  The function of myosin and myosin light chain 
kinase phosphorylation in smooth muscle.  Annu Rev Pharmacol Toxicol.  25(593-620. 
Karagiannis, P. and F. V. Brozovich.  2003.  The kinetic properties of smooth muscle: 
how a little extra weight makes myosin faster.  J Muscle Res Cell Motil.  24(2-3):  157-
63. 
Kaverina, I., T. E. Stradal and M. Gimona.  2003.  Podosome formation in cultured A7r5 
vascular smooth muscle cells requires Arp2/3-dependent de-novo actin polymerization at 
discrete microdomains.  J Cell Sci.  116(Pt 24):  4915-24. 
Kenworthy, A. K.  2001.  Imaging protein-protein interactions using fluorescence 
resonance energy transfer microscopy.  Methods.  24(3):  289-96. 
Kishi, H., T. Mikawa, M. Seto, Y. Sasaki, T. Kanayasu-Toyoda, T. Yamaguchi, M. 
Imamura, M. Ito, H. Karaki, J. Bao, A. Nakamura, R. Ishikawa and K. Kohama.  2000.  
Stable transfectants of smooth muscle cell line lacking the expression of myosin light 
chain kinase and their characterization with respect to the actomyosin system.  J Biol 
Chem.  275(2):  1414-20. 
Kohama, K., T. Okagaki, K. Hayakawa, Y. Lin and R. Ishikawa.  1992.  A novel 
regulatory effect of smooth muscle myosin light chain kinase on ATP-dependent actin-
myosin interaction.  Jpn J Pharmacol.  58 Suppl 2(347P). 
Krymsky, M. A., D. S. Kudryashov, V. P. Shirinsky, T. J. Lukas, D. M. Watterson and A. 
V. Vorotnikov.  2001.  Phosphorylation of kinase-related protein (telokin) in tonic and 
phasic smooth muscles.  J Muscle Res Cell Motil.  22(5):  425-37. 
Kudryashov, D. S., O. V. Stepanova, E. L. Vilitkevich, T. A. Nikonenko, E. S. 
Nadezhdina, N. A. Shanina, T. J. Lukas, L. J. Van Eldik, D. M. Watterson and V. P. 
Shirinsky.  2004.  Myosin light chain kinase (210 kDa) is a potential cytoskeleton 
integrator through its unique N-terminal domain.  Exp Cell Res.  298(2):  407-17. 
Lehman, W., P. Vibert, R. Craig and M. Barany.  1996.  Actin and the structure of 
smooth muscle thin filaments, Biochemistry of smooth muscle contraction.  Academic 
Press.  1st edition, 47-58. 
Li, C., M. E. Fultz, W. Geng, S. Ohno, M. Norton and G. L. Wright.  2001a.  
Concentration-dependent phorbol stimulation of PKCalpha localization at the nucleus or 
subplasmalemma in A7r5 cells.  Pflugers Arch.  443(1):  38-47. 
 34
Li, C., M. E. Fultz, J. Parkash, W. B. Rhoten and G. L. Wright.  2001b.  Ca2+-dependent 
actin remodeling in the contracting A7r5 cell.  J Muscle Res Cell Motil.  22(6):  521-34. 
Lin, P., K. Luby-Phelps and J. T. Stull.  1997.  Binding of myosin light chain kinase to 
cellular actin-myosin filaments.  J Biol Chem.  272(11):  7412-20. 
Lin, P., K. Luby-Phelps and J. T. Stull.  1999.  Properties of filament-bound myosin light 
chain kinase.  J Biol Chem.  274(9):  5987-94. 
Linder, S. and M. Aepfelbacher.  2003.  Podosomes: adhesion hot-spots of invasive cells.  
Trends Cell Biol.  13(7):  376-85. 
Linder, S. and P. Kopp.  2005.  Podosomes at a glance.  J Cell Sci.  118(Pt 10):  2079-82. 
Marston, S. B. and P. A. J. Huber.  1996.  Caldesmon, Biochemistry of smooth muscle 
contraction.  Academic Press.  1st edition, 77-88. 
Mietus-Snyder, M., A. Friera, C. K. Glass and R. E. Pitas.  1997.  Regulation of 
scavenger receptor expression in smooth muscle cells by protein kinase C: a role for 
oxidative stress.  Arterioscler Thromb Vasc Biol.  17(5):  969-78. 
Miura, M., T. Iwanaga, K. M. Ito, M. Seto, Y. Sasaki and K. Ito.  1997.  The role of 
myosin light chain kinase-dependent phosphorylation of myosin light chain in phorbol 
ester-induced contraction of rabbit aorta.  Pflugers Arch.  434(6):  685-93. 
Moreau, V., F. Tatin, C. Varon, G. Anies, C. Savona-Baron and E. Genot.  2006.  Cdc42-
driven podosome formation in endothelial cells.  Eur J Cell Biol.  85(3-4):  319-25. 
Moreau, V., F. Tatin, C. Varon and E. Genot.  2003.  Actin can reorganize into 
podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA.  Mol 
Cell Biol.  23(19):  6809-22. 
Mueller, S. C. and W. T. Chen.  1991.  Cellular invasion into matrix beads: localization 
of beta 1 integrins and fibronectin to the invadopodia.  J Cell Sci.  99 ( Pt 2)(213-25. 
Mueller, S. C., Y. Yeh and W. T. Chen.  1992.  Tyrosine phosphorylation of membrane 
proteins mediates cellular invasion by transformed cells.  J Cell Biol.  119(5):  1309-25. 
Murphy, R. A., P. H. Ratz and C. M. Hai.  1987.  Determinants of the latch state in 
vascular smooth muscle.  Prog Clin Biol Res.  245(411-3. 
Murphy, R. A., J. S. Walker and J. D. Strauss.  1997.  Myosin isoforms and functional 
diversity in vertebrate smooth muscle.  Comp Biochem Physiol B Biochem Mol Biol.  
117(1):  51-60. 
Murphy, R. A. and C. M. Rembold.  2005.  The latch-bridge hypothesis of smooth 
muscle contraction.  Can J Physiol Pharmacol.  83(10):  857-64. 
 
 35
Nguyen, A. and H. Cai.  2006.  Netrin-1 induces angiogenesis via a DCC-dependent 
ERK1/2-eNOS feed-forward mechanism.  Proc Natl Acad Sci U S A.  103(17):  6530-5. 
North, A. J., M. Gimona, Z. Lando and J. V. Small.  1994.  Actin isoform compartments 
in chicken gizzard smooth muscle cells.  J Cell Sci.  107 ( Pt 3)(445-55. 
Oishi, K., H. Takano-Ohmuro, N. Minakawa-Matsuo, O. Suga, H. Karibe, K. Kohama 
and M. K. Uchida.  1991.  Oxytocin contracts rat uterine smooth muscle in Ca2(+)-free 
medium without any phosphorylation of myosin light chain.  Biochem Biophys Res 
Commun.  176(1):  122-8. 
Poperechnaya, A., O. Varlamova, P. J. Lin, J. T. Stull and A. R. Bresnick.  2000.  
Localization and activity of myosin light chain kinase isoforms during the cell cycle.  J 
Cell Biol.  151(3):  697-708. 
Rovner, A. S., P. M. Fagnant, S. Lowey and K. M. Trybus.  2002.  The carboxyl-terminal 
isoforms of smooth muscle myosin heavy chain determine thick filament assembly 
properties.  J Cell Biol.  156(1):  113-23. 
Shirinsky, V. P., A. V. Vorotnikov, K. G. Birukov, A. K. Nanaev, M. Collinge, T. J. 
Lukas, J. R. Sellers and D. M. Watterson.  1993.  A kinase-related protein stabilizes 
unphosphorylated smooth muscle myosin minifilaments in the presence of ATP.  J Biol 
Chem.  268(22):  16578-83. 
Simmen, R. C., B. S. Dunbar, V. Guerriero, J. G. Chafouleas, J. H. Clark and A. R. 
Means.  1984.  Estrogen stimulates the transient association of calmodulin and myosin 
light chain kinase with the chicken liver nuclear matrix.  J Cell Biol.  99(2):  588-93. 
Singer, H. A.  1990.  Phorbol ester-induced stress and myosin light chain phosphorylation 
in swine carotid medial smooth muscle.  J Pharmacol Exp Ther.  252(3):  1068-74. 
Small, J. V. and M. Gimona.  1998.  The cytoskeleton of the vertebrate smooth muscle 
cell.  Acta Physiol Scand.  164(4):  341-8. 
Smith, L., M. Parizi-Robinson, M. S. Zhu, G. Zhi, R. Fukui, K. E. Kamm and J. T. Stull.  
2002.  Properties of long myosin light chain kinase binding to F-actin in vitro and in vivo.  
J Biol Chem.  277(38):  35597-604. 
Smith, L., X. Su, P. Lin, G. Zhi and J. T. Stull.  1999.  Identification of a novel actin 
binding motif in smooth muscle myosin light chain kinase.  J Biol Chem.  274(41):  
29433-8. 
Somlyo, A. P. and A. V. Somlyo.  2003.  Ca2+ sensitivity of smooth muscle and 
nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.  
Physiol Rev.  83(4):  1325-58. 
 36
Song, J., B. E. Rolfe, I. P. Hayward, G. R. Campbell and J. H. Campbell.  2000.  Effects 
of collagen gel configuration on behavior of vascular smooth muscle cells in vitro: 
association with vascular morphogenesis.  In Vitro Cell Dev Biol Anim.  36(9):  600-10. 
Song, J., B. E. Rolfe, I. P. Hayward, G. R. Campbell and J. H. Campbell.  2001.  
Reorganization of structural proteins in vascular smooth muscle cells grown in collagen 
gel and basement membrane matrices (Matrigel): a comparison with their in situ 
counterparts.  J Struct Biol.  133(1):  43-54. 
Song, L., J. J. Moon, H. Maio, G. Jin, P. C. Benjamin, Y. Suli, H. Yingli, U. Shunichi 
and S. Chien.  2003.  Signal transduction in matrix contraction and the migration of 
vascular smooth muscle cells in three-dimensional matrix.  J. Vas. Res.  40(378-388. 
Stull, J. T., K. E. Kamm, J. K. Krueger, P. Lin, K. Luby-Phelps and G. Zhi.  1997.  
Ca2+/calmodulin-dependent myosin light-chain kinases.  Adv Second Messenger 
Phosphoprotein Res.  31(141-50. 
Stull, J. T., J. K. Krueger, K. E. Kamm, Z.-H. Gao, G. Zhi and R. Padre.  1996.  Myosin 
light chain kinase, Biochemistry of smooth muscle contraction.  Academic Press.  1st 
edition, 119-128. 
Stull, J. T., P. J. Lin, J. K. Krueger, J. Trewhella and G. Zhi.  1998.  Myosin light chain 
kinase: functional domains and structural motifs.  Acta Physiol Scand.  164(4):  471-82. 
Tamariz, E. and F. Grinnell.  2002.  Modulation of fibroblast morphology and adhesion 
during collagen matrix remodeling.  Mol Biol Cell.  13(11):  3915-29. 
Tatin, F., C. Varon, E. Genot and V. Moreau.  2006.  A signalling cascade involving 
PKC, Src and Cdc42 regulates podosome assembly in cultured endothelial cells in 
response to phorbol ester.  J Cell Sci.  119(Pt 4):  769-81. 
Trybus, K. M.  1996.  Myosin regulation and assembly, Biochemistry of smooth muscle 
contraction.  Academic Press.  1st edition, 37-45. 
Varon, C., C. Basoni, E. Reuzeau, V. Moreau, I. J. Kramer and E. Genot.  2006a.  
TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases 
Rac1 and RhoA.  Exp Cell Res.  312(18):  3604-19. 
Varon, C., F. Tatin, V. Moreau, E. Van Obberghen-Schilling, S. Fernandez-Sauze, E. 
Reuzeau, I. Kramer and E. Genot.  2006b.  Transforming growth factor beta induces 
rosettes of podosomes in primary aortic endothelial cells.  Mol Cell Biol.  26(9):  3582-
94. 
Vorotnikov, A. V., M. A. Krymsky and V. P. Shirinsky.  2002.  Signal transduction and 
protein phosphorylation in smooth muscle contraction.  Biochemistry (Mosc).  67(12):  
1309-28. 
 37
Woessner, J. F. and H. Nagase.  2000.  Matrix metalloproteinases and TIMPs, Protein 
Profile.  Oxford Press.  1-223. 
Wright, G. and E. Hurn.  1994.  Cytochalasin inhibition of slow tension increase in rat 
aortic rings.  Am J Physiol.  267(4 Pt 2):  H1437-46. 
Wright, G. L. and A. S. Battistella-Patterson.  1998.  Involvement of the cytoskeleton in 
calcium-dependent stress relaxation of rat aortic smooth muscle.  J Muscle Res Cell 
Motil.  19(4):  405-14. 
Ye, L. H., K. Hayakawa, H. Kishi, M. Imamura, A. Nakamura, T. Okagaki, T. Takagi, A. 
Iwata, T. Tanaka and K. Kohama.  1997.  The structure and function of the actin-binding 
domain of myosin light chain kinase of smooth muscle.  J Biol Chem.  272(51):  32182-9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38
Chapter Two 
MLCK/Actin Interaction in the Contracting A7r5 Cell 
 
 
 
Thatcher1 SE, Fultz3 ME, Wright1 C, Tanaka2 H, Kohama2 K, and Wright1 GL. 
 
1Department of Pharmacology, Physiology, and Toxicology, The Joan C. Edwards 
School of Medicine, Marshall University, Huntington, WV 25704. 
 
2Department of Molecular and Cellular Pharmacology, Gunma University, Maebashi, 
Japan 
 
3Department of Biology, Morehead State University, Morehead, KY 40351. 
 
 
 
 
 
 
 
Correspondence to: 
Gary L. Wright 
Professor of Pharmacology, Physiology, and Toxicology 
The Joan C. Edwards School of Medicine 
Marshall University 
Huntington, WV 25704 USA 
Phone:  304 696 7368 
Fax:  304 696 7381 
E-mail:  wrightg@marshall.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
Running title:  MLCK/Actin interaction in contracting cells 
 
 39
Abstract 
 
Previous work has suggested that in addition to its kinase activity, myosin light chain 
kinase exhibits non-kinase properties that could influence cytoskeletal organization.   
Colocalization imaging and fluorescence resonance energy transfer (FRET) analysis 
indicated α-actin/MLCK association in resting cells and in podosomes of phorbol 12,13-
dibutyrate (PDBu)-stimulated A7r5 smooth muscle cells.  By comparison, β-actin/MLCK 
association was observed in stress fibers and in diffuse distribution in the perinuclear 
region of both control and PDBu-treated cells.  Downregulation of MLCK by siRNA 
transfection resulted in variable patterns of actin isoform reorganization in control cells.  
α-Actin formed a dense system of filaments at the cell periphery leaving the central 
region of the cells devoid of structure.  In contrast, β-actin stress fibers disassembled with 
this isoform diffusely distributed in the cell.  In PDBu-treated cells, transfection with 
MLCK-siRNA resulted in an approximate 70% reduction in the formation of podosomes.  
The introduction of a peptide containing the 1-41 N-terminal amino acid sequence of 
MLCK by peptide-mediated uptake or microinjection resulted in loss of α-actin stress 
fibers from the central region of the cell.  The results indicate that MLCK plays an 
important role in maintaining α- and β-actin stress fibers and in the phorbol ester-induced 
reorganization of these isoforms.  Furthermore, this role appears to be related to the N-
terminal actin binding properties of the kinase.                                                       
 
 
 
 
 
Keywords:  cytoskeleton, remodeling, podosomes, phorbol, FRET 
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Introduction 
 
Myosin light chain kinase (MLCK) is a serine/threonine kinase important in the 
regulation of smooth muscle contraction (Kamm KE, 1985, Kamm and Stull, 1985).  
Two isoforms of MLCK have been identified (Bao et al., 2002, Poperechnaya et al., 
2000) in cultured endothelial and smooth muscle cells.  The larger 210 kDa isoform is 
thought to serve primarily in cytokinesis and cell division and interacts not only with 
actin but with microtubules as well (Kudryashov et al., 2004).  Downregulation of the 
smaller 130 kDa isoform has suggested that this kinase is directly involved in smooth 
muscle contraction (Bao et al., 2002).   In the presence of Ca2+/calmodulin (CaM) 
complex, MLCK phosphorylates the serine-19 residue of the myosin regulatory light 
chains, activating myosin ATPase activity with subsequent force development (Kamm 
and Stull, 1985).  In addition to its site of kinase activity located in the central region of 
the molecule, MLCK has multiple actin binding sites at its N-terminal (Kohama et al., 
1992) and myosin binding activity at its C-terminal (Ito et al., 1989).  Although research 
interest has centered on the kinase properties of MLCK, there is some evidence to 
suggest the enzyme is a multifunctional protein.  For example, it is proposed that when 
myosin is fully phosphorylated MLCK exerts an inhibitory effect through its actin-
binding domain and that MLCK binding of myosin could contribute to sustained force 
maintenance in smooth muscle (Gao et al., 2001). 
 
Of particular interest is the in vitro observation that MLCK crosslinks actin filaments to 
form bundles and that this activity is abolished in the presence of Ca2+/CaM complex 
(Hayakawa et al., 1999b).  It has long been known that the N-terminus of MLCK is 
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necessary for binding to actin filaments (Lin et al., 1997, Smith et al., 1999).  
Competitive binding studies have suggested MLCK contains two actin binding regions at 
residues 26-41 and 138-218 (Gao et al., 2001).  In addition, Ca2+/CaM binding sites have 
been identified at 26-41 and 787-815 residues (Ye et al., 1997).  The 787-815 site 
regulates the kinase domain; whereas, the binding of Ca2+/CaM at the 26-41 site inhibits 
actin binding and actin filament bundling.  Taken together, these findings suggest the 
possibility of a mechanism for the simultaneous activation of myosin ATPase activity and 
the strategic release of crosslinked actin filaments for sliding filament force development.  
However, to our knowledge, the physiological role of MLCK in actin filament bundling 
has not been investigated. 
 
In the present study, we utilized MLCK-siRNA and competitive binding of peptides 
containing the MLCK N-terminal actin binding site to evaluate the influence of MLCK 
on actin cytoskeletal structure in resting and contracted A7r5 smooth muscle cells.  The 
results suggest that the actin binding properties of MLCK play an important role in 
determining actin cytoskeletal organization.  
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Materials & Methods 
Chemicals.  Unless otherwise stated all reagents were purchased from Sigma (St. Louis, 
MO). 
 
Cell Culture.  A7r5 cells are derived from embryonic rat thoracic aorta and were 
purchased from ATCC (Manassas, VA).  Cells were plated on 75 cm2 flasks and grown 
to approximately 85% confluence at 37°C in a humidified atmosphere of 5% CO2 in air.  
The cells were maintained in Dulbecco’s modified Eagles medium (DMEM) (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum, 100 U/mL penicillin G, and 
100 µg/mL streptomycin.  Medium was changed every other day and cells were passaged 
at least once a week.  Passaging was accomplished by addition of a trypsin/EDTA 
solution (Invitrogen, Carlsbad, CA) in phosphate-buffered saline (PBS) and collection of 
cells by centrifugation. 
 
Immunocytochemistry.  A7r5 cells were seeded on ethanol-flamed 22 x 22 mm, 
thickness 1 coverslips (Fisher, Inc., Chicago, IL) and allowed to grow for 24-48 hours.  
Cells were stimulated with phorbol 12, 13-dibutyrate (PDBu, 10-7M) for a period of 30 
minutes.  After stimulation, cells were fixed and permeabilized with ice-cold acetone for 
a period of 1 minute.  Cells were then washed 3 times with PBS/0.5% Tween-20 (PBS-T) 
pH 7.5, followed by incubation in blocking solution containing 5% nonfat dry milk in 
PBS for 1 hour.  MLCK staining was accomplished by incubation of cells in a 1:100 
dilution of monoclonal MLCK clone K36, overnight at 4°C.  Subsequently, cells were 
rinsed 3 times in PBS-T followed by an Alexa 488 anti-mouse IgG secondary antibody 
(Molecular Probes, Eugene, OR) at a 1:100 dilution for 1 hour.  After rinsing in PBS-T, 
cells were reblocked in 5% nonfat milk to prevent cross-talk between the two primary 
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antibodies and were then stained for actin by incubation with α-actin clone 1A4, or β-
actin clone AC-15 for 1 hour.  Cells were rinsed 3 times in PBS-T followed by an Alexa 
568 anti-mouse IgG secondary antibody (Molecular Probes, Eugene, OR) at a 1:100 
dilution for 1 hour.  Finally, cells were rinsed 3 times in PBS-T and mounted in Gel 
Mount medium (Biomeda Inc, Foster City, CA).     
 
Confocal/FRET Microscopy.  Immunostained cells were mounted on a Nikon Diaphot 
microscope and confocal microscopy was performed with a BioRad Model 1024 
scanning system equipped with a krypton/argon laser.  For FRET analysis, MLCK was 
labeled with Alexa 488 and served as the donor component of the system.  α-Actin and 
β-actin were labeled with Alexa 568 and served as the acceptor molecules.  The donor 
molecule (MLCK) was directly excited and the resulting emission was obtained with a 
522DF32 bandpass filter.  However, a portion of the energy of emission was transferred 
to neighboring Alexa 568 fluorophore resulting in emission that was captured on a 
second channel with a HQ598/40 bandpass filter.  Subsequently, the sample was excited 
at the 568 nm laser line at 100% power to photobleach the acceptor (α-actin, β-actin) 
molecule and a second image of the cell was acquired again at the 488 nm laser line with 
the multichannel set to obtain MLCK fluorescence (522DF32) and to verify the absence 
of acceptor label 568 emission (HQ598/40).  An intensity profile was generated for each 
image (Image J Software, NIH) and the resulting plot was analyzed with Peakfit V4.11 
software (SPSS Science, Richmond, CA) to obtain the area under the curve.  The values 
were then used to calculate the increase in fluorescence intensity after photobleaching.  
Because resonance energy transfer can only occur if the donor and acceptor molecules 
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are sufficiently close to one another, the resulting values were analyzed in comparison of 
treated and control cells as an index of the association between MLCK and either α- or β-
actin.  To evaluate the responsiveness of the FRET system as presently employed, a 
series of control experiments were performed.  As a positive control, cells were incubated 
with either α- or β-actin specific antibodies labeled with both donor and acceptor 
fluorophores.  In these experiments it was expected that the increased availability of 
closely associated binding sites would result in a significant increase in the FRET effect 
compared to the MLCK/actin evaluations.  As a negative control, FRET analysis was 
performed on the association of α- and β-actin with the α-subunit of the calcium receptor 
located in the plasma membrane.  In this case, it was expected that the FRET effect 
would be negligible.  In addition, FRET analysis of MLCK/actin was conducted in the 
absence of acceptor fluorophore or donor fluorophore to evaluate the effects of 
autofluorescence and signal bleedthrough on results.    
 
Generation and transfection of siRNA.  A total of four siRNAs were developed against 
the C-terminal region of MLCK based on DNA sequence data obtained from NCBI’s 
database, accession XP-213611 and derived from EST data via gene prediction method 
(GNOMON) and using the Ambion Target Finder: 
 5’-AATGAATCCTGGACGAAGACACCTGTCTC-3’ (Sense target 44) 
5’-AAACAGAAGCAGGTCCTAAGTCCTGTCTC-3’ (Antisense target 44) 
5’-AAGTCAGTTTAGATCGTCGCGCCTGTCTC-3’ (Sense target 28) 
5’-AAGCGCTGCTAGATTTGACTGCCTGTCTC-3’ (Antisense target 28) 
5’-AATCTGAGATCGAAGAGACGTCCTGTCTC-3’ (Sense target 20) 
5’-AATGCAGAGAAGCTAGAGTCTCCTGTCTC-3’ (Antisense target 20) 
5’-AAATACATGGCAAGAAGGAAGCCTGTCTC-3’ (Antisense target 9) 
5’-AAGAAGGAAGAACGGTACATACCTGTCTC-3’ (Sense target 9) 
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Each sequence was subjected to a blast search to ensure specificity for MLCK.  
Subsequently, siRNAs were constructed using Silencer siRNA construction kits 
(Ambion, Austin, TX) and transfections were performed using Oligofectamine 
(Invitrogen, Carlsbad, CA).  Transfection efficiency was evaluated by labeling siRNAs 
with Cy3 using the Silencer siRNA labeling kit (Ambion, Austin, TX) (data not shown).  
The concentration of each siRNA was determined using a NanoDrop ND-1000 
spectrophotometer (Nanodrop, Wilmington, DE) at a 260 nm wavelength.  The four 
siRNAs were then prepared as a cocktail containing equal concentrations of each 
inhibitor. 
 
To evaluate the effects of the downregulation of MLCK on actin cytoskeletal structure, 
cells were seeded onto glass coverslips, placed in 6-well culture dishes and allowed 24 
hours for attachment.  Subsequently, 50 nM siRNA/oligofectamine in Opti-Mem I was 
added to each well for a 5 hour incubation.  The samples were then rinsed three times and 
returned to the incubator for 24 hours prior to experimentation.  Control cells for these 
experiments were transfected with RISC-Free siRNA #1 (negative control) (Dharmacon 
RNA technologies, Lafayette, CO). 
 
Western Blots.  A7r5 cells were seeded on 100 mm culture plates and allowed to grow to 
confluence.  The cells were then transfected with MLCK-siRNA cocktail or nonsense-
siRNA (negative control) or Lamin A/C siRNA (positive control) (Dharmacon RNA 
technologies, Lafayette, CO) and returned to the incubator for 24 hours.  The samples 
were then trypsinized and the cells pelleted by centrifugation.  The pellet was rinsed and 
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then suspended in lysis buffer (10 mM MOPS, 1% NP-40, 5 mM EDTA, 0.5 mM EGTA, 
1 mM DTT, 50 mM MgCl2, 300 mM NaCl, 1 mM PMSF, 50 µg/mL leupeptin, 
chymostatin, and pepstatin A) and sonicated for 10 seconds at a low setting.  The sample 
was again centrifuged and the protein concentration of the supernatant determined by 
BCA analysis (Pierce, Rockford, IL).  The sample was then run on 8% and 12% 
polyacrylamide gels.  Gels were blotted on PVDF membranes and probed with MLCK 
(K36 clone), Lamin A/C (mab636 clone) (Affinity Bioreagents, Golden, CO) and 
GAPDH (6C5 clone) (Ambion, Austin, TX) antibodies.  Blots were visualized by 
chemiluminescence with ECL reagents (Amersham Pharmacia Biotech, Piscataway, NJ) 
and scanned using an Epson 2580 photo scanner.  Autoradiograms were analyzed by 
Image J software. 
 
Effects of MLCK N-terminus peptides.  In a final series of experiments, we examined the 
effects of peptides containing the N-terminal CaM-sensitive actin binding site of MLCK 
on actin cytoskeletal structure in unstimulated A7r5 cells.  Peptides containing the 1-25 
(NH2-MDFRANLQRQVKPKTLSEEERKVHG-COOH), 26-41 (NH2-
PQQVDFRSVLAKKGTP-COOH), and 1-41 N-terminal amino acid sequence of MLCK 
were conjugated to a peptide (NH2-CRQIKIWFQNRRMKWKK-COOH) derived from 
Drosophila antennapedia homeodomain protein and have been shown to facilitate cellular 
uptake of peptides (Chen et al., 2001).  The conjugated peptides were dissolved in 
DMEM at a concentration of 2.0 mg/mL and added to cells for 30 minutes.  The cells 
were then rinsed and fixed with ice cold acetone for immunostaining and imaging.  In a 
second study, the MLCK peptides were introduced directly into the cell by 
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microinjection.  Cells were injected with a Pneumatic Pico Pump (World Precision 
Instruments, Sarasota, FL) at a pressure setting of 5 and time constant of 2 seconds using 
glass pipets pulled with a Flaming Brown Micropipette Puller (Sutter Instruments Co., 
Novato, CA).  Peptide was dissolved (25 mg/mL) in injection buffer (10 mM Alexa 594 
fluor in 200 mM KCl) while control cells received buffer only.  Following injection, cells 
were returned to the incubator for a two hour recovery period prior to fixation and 
staining. 
 
Time lapse phase-contrast microscopy.  A7r5 cells were seeded in 35 mm culture dishes 
and treated with MLCK-siRNA or RISC-free siRNA #1.  Cells were rinsed and incubated 
with CO2-Independent DMEM (Invitrogen) supplemented with 1X GlutaMax-I 
(Invitrogen), pen-strep, and 10% FCS.  Culture dishes were placed in a DH-35 Culture 
Dish Heater attached to a TC-324B Heat Controller (Warner Instruments, Hamden CT) 
and incubated at 37°C.  Cells were then treated with PDBu with contractions monitored 
every 10 minutes for a total time of 140 minutes.  Phase-contrast images were obtained 
with a 10X objective and a Nikon D70 SLR camera attached to a Nikon microscope.   
 
Myosin Light Chain Phosphorylation at Serine-19/20 Site.  A7r5 cells were seeded on 
coverslips and placed in 6-well plates.  Cells were stimulated with phorbol esters at a 
concentration of 10-7M for 30 minutes.  Cells were fixed with 2% paraformaldehyde for 
15 minutes and permeabilized with 0.1% Triton X-100 for 20 minutes.  Fixed samples 
were then blocked in 5% nonfat milk and treated with a rabbit anti-phospho-MLC 
antibody against the serine-19/20 site for 1 hour at a dilution of 1:100 (Rockland, 
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Gilbertsville, PA).  Alexa 488 rabbit anti-IgG was used as the secondary antibody at a 
dilution of 1:100 for a period of 1 hour.  Cells were rinsed with PBS-T and mounted 
according to immunocytochemistry protocol.   
 
Statistics.  All experiments were performed in triplicate unless otherwise indicated.  
Differences between treatment groups were evaluated by Students’ t-tests and one-way 
ANOVA using Sigma Stat V.2.03 (SPSS Science Inc., San Rafael, CA).  Differences 
were considered significant at p<0.05.  Results are presented as mean ± SEM throughout 
the figures. 
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Results 
Colocalization imaging of unstimulated cells indicated that α-actin was incorporated into 
a dense system of stress fibers spanning the cell with MLCK diffusely distributed 
throughout the cell body (Fig. 4).  In PDBu-contracted cells there was a loss in α-actin 
stress fibers with translocation of both α-actin and MLCK to podosomes (intensely 
staining bodies located in the peripheral region of the cell).  By comparison, β-actin was 
present in stress fibers in both control and PDBu-treated cells (Fig. 5).  MLCK appeared 
to be strongly colocalized with β-actin in stress fibers as well as in a diffuse structure 
located in the perinuclear region of the cell.  FRET analysis revealed a strong association 
of α-actin and MLCK in stress fibers of control cells that was not apparent in 
colocalization images and verified α-actin/MLCK association in podosomes (Fig. 6).  
Moreover, these results suggested that the α-actin/MLCK association increased 
significantly (87%) in PDBu-contracted cells (Table 3a).  FRET analysis also verified β-
actin/MLCK association in stress fibers and the perinuclear structure of control and 
PDBu-treated cells (Fig. 7).  However, unlike the α-actin/MLCK complex, β-
actin/MLCK association was unchanged between control and PDBu-contracted cells 
(Table 3a).  To our knowledge, this is the first study to demonstrate MLCK association 
with α-actin at podosomes.  Furthermore, the results suggest recruitment of α-
actin/MLCK association during phorbol ester-mediated contraction of the cell. 
 
As a part of these studies, a series of control experiments were conducted to evaluate the 
possibility that nonspecific effects or other artifact contributed to FRET results.  The 
responsiveness of the system to increased availability of closely associated antibody 
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binding sites (positive control) was tested by incubating α- or β-actin specific antibodies 
(1:1 ratio) with donor and acceptor fluorophores (Fig 8A).  As expected, the increase in 
donor molecule fluorescent intensity after photobleaching of the acceptor fluorophore 
was significantly greater in these actin/actin comparisons than obtained in actin/MLCK 
analyses (Table 3b).  Similarly expected, FRET analysis of the association of α- and β-
actin with the α-subunit of the calcium receptor located in the plasma membrane 
(negative control) showed no change in donor fluorescence after photobleaching of the 
acceptor fluorophore (Fig 8B, Table 3c).  Finally, donor fluorophore labeling of MLCK 
in the absence of acceptor fluorophore or the labeling of actin isoforms in the absence of 
donor fluorophore yielded negligible changes in donor fluorescence following the 
photobleaching procedure (data not shown) indicating insignificant effects of 
autofluorescence and signal bleedthrough on the FRET system.  The results suggest that 
FRET analysis, as presently employed, may provide a good indication of protein-protein 
interaction. 
 
In a final series of experiments, we tested the hypothesis that MLCK contributed to 
cytoskeletal structural integrity through its actin binding properties.  Western analysis 
indicated only the presence of the 130 kDa isoform of MLCK in A7r5 cells.  Western 
analysis (Fig 9a,b) and evaluation by immunofluorescence (Fig 9c, Table 4) further 
indicated an average 40% and 55% downregulation of 130 kDa MLCK content, 
respectively, in cells treated with MLCK-siRNA.  Immunofluorescence studies further 
suggested a wide range of fluorescence intensities among these cells with the majority of 
MLCK-siRNA-treated cells (72.1%) at <1000 pixel counts compared to 3.2% of negative 
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control cells (Table 4).  Consequently, the actin cytoskeletal structure of MLCK-siRNA-
treated cells at <1000 pixel counts was compared with negative control cells at a 1000-
2000 pixel fluorescent intensity range. 
 
Negative controls showed typical α- and β-actin stress fibers in unstimulated cells (Fig 
10).  By comparison, MLCK-siRNA treated cells exhibited a loss in stress fibers with cell 
rounding.  Interestingly, the effect of MLCK downregulation was different on α-actin 
versus β-actin structure.  α-Actin formed a dense system of fibers at the cell periphery 
with the cell center devoid of structure.  In contrast, β-actin stress fibers were generally 
absent in MLCK-siRNA-treated cells with this isoform concentrated in a network 
formation in the perinuclear region of the cell.  Stimulation of negative control cells with 
10-7 M PDBu resulted in the translocation of α-actin (50.2 ± 5.3% of cells) and β-actin 
(23.8 ± 2.6% of cells) to podosomes (Table 5, Fig. 11).  MLCK-siRNA treatment of cells 
resulted in an approximate 70% reduction in podosome formation.  Despite PDBu 
addition, these cells remained similar in appearance to unstimulated cells with peripheral 
α-actin stress fibers and diffuse distribution of β-actin with the cell. 
 
The introduction of peptides containing 1-41 but not the 1-25 N-terminal amino acid 
sequence of MLCK into the cell either by peptide-induced uptake (Fig. 12) or by 
microinjection (Fig. 13) resulted in a loss in α-actin stress fibers in the central region of 
the cell similar in appearance to that seen in cells treated with MLCK-siRNA.   
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The majority of control cells (76.7 ± 2.8%) responded to phorbol esters with robust 
constriction (Fig. 14).  By comparison, only 26.6 ± 6.3% of MLCK-siRNA treated cells 
showed evidence of responsiveness to phorbol.  Surprisingly, the levels of 
phosphorylated MLC were similar between control and siRNA-treated cells (Fig. 15). 
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Discussion 
Earlier work has indicated that MLCK has at least two actin binding regions and may 
crosslink actin filaments to form bundles (Gao et al., 2001, Hayakawa et al., 1999b).  In 
addition to actin and myosin binding, MLCK contains two Ca2+/CaM binding sites, one 
of which serves to activate kinase activity while the other negatively regulates actin 
binding at the N-terminal 26-41 actin binding site.  Moreover, there is evidence to 
suggest that the binding affinity of the two sites is similar and that the actin binding site 
could bind Ca2+/CaM under physiological conditions (Hayakawa et al., 1999b).  Based on 
these observations, we speculated that MLCK crosslinking of actin filaments could be 
important in contributing to the organization of actin components of the contractile 
apparatus in smooth muscle.  In the present study, we investigated the effect of 
downregulation of MLCK and use of peptides to competitively inhibit actin binding at 
the 26-41 site on actin structure in resting and PDBu-contracted A7r5 smooth muscle 
cells.  Because the phorbol-induced contraction occurs in the absence of elevation in 
[Ca]i in these cells (Nakajima et al., 1993), cells in both resting and stimulated conditions 
were expected to exhibit the influence of MLCK actin filament crosslinking activity. 
 
Whole cell FRET analysis, as presently employed, has been used successfully to evaluate 
protein-protein interactions in A7r5 cells (Dykes et al., 2003).  Because the 
donor/acceptor must be within 10 nm distance from each other for efficient energy 
transfer (dos Remedios et al., 1987, Kenworthy, 2001) this technique provides a measure 
of protein-protein distances compatible with molecular interaction.  FRET analysis 
indicated dynamic changes in the α-actin/MLCK contractile protein during the course of 
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PDBu-induced contraction and provided clearer resolution of actin/MLCK associated 
structure compared to that obtained with colocalization imaging.  As expected, the 
labeling of actin with both donor and acceptor fluorophores resulted in a significantly 
higher FRET index than obtained for actin/MLCK while analysis of the association of 
actin with the α-subunit of the calcium channel located in the plasma membrane showed 
no FRET effect.  These results suggest that whole cell FRET analysis is responsive to 
changes in protein-protein associations and can be used as a tool for assessing these 
interactions in fixed samples. 
 
Use of colocalization and FRET analysis indicated a significant association of MLCK 
with α- and β-actin in stress fibers of unstimulated A7r5 cells.  This was particularly 
evident in FRET images which indicated significant quenching of the donor component 
(Fig. 6).  As previously reported (Fultz et al., 2000), PDBu-induced contraction resulted 
in the reorganization of α-actin into podosomes; whereas, β-actin was retained in stress 
fibers.  In these cells, MLCK was observed in association with α-actin in podosomes and 
β-actin in stress fibers.  Most notably, FRET analysis indicated an approximate 87% 
increase in α-actin/MLCK complex while β-actin/MLCK association was unchanged in 
contracted cells (Table 3).  Taken together, these results indicated significant levels of 
actin/MLCK interaction in specific structures and that recruitment of α-actin/MLCK 
interaction may be important in the PDBu-induced contraction and actin reorganization in 
A7r5 cells. 
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MLCK-siRNA downregulation of MLCK resulted in a highly reproducible and 
characteristic change in actin structure.  Unstimulated cells showed a general dissolution 
of β-actin with the loss of α-actin stress fibers from the central region of the cell.  
Reductions in the cellular content of MLCK were also observed to severely restrict the 
formation of podosomes in PDBu-treated cells.  These results suggest a stabilizing 
influence of MLCK on actin stress fibers in resting cells and that the kinase plays an 
important role in contractile remodeling of actin.  While these findings are consistent 
with an effect of MLCK crosslinking activity, internal strain can result in stress fiber 
formation (Chrzanowska-Wodnicka and Burridge, 1996) and a loss in basal MLCK 
kinase activity could have also contributed to results in these experiments. 
 
Peptides containing the 26-41 N-terminal sequence have been successfully utilized to 
competitively inhibit MLCK at its Ca2+/CaM-sensitive actin binding site (Gao et al., 
2001).  In the presence of these peptides or Ca2+/CaM, actin binding is inhibited leaving 
MLCK bound to actin filaments at a second, Ca2+/CaM-insensitive site.  Because the 
Ca2+/CaM binding affinity is similar at the 26-41 actin binding site and the 787-815 
kinase activation site, it is likely that actin binding at this site is inhibited concurrent with 
activation of ATPase activity.  Hence, there is little reason to believe that disassociation 
of MLCK from actin at the Ca2+/CaM site would negatively affect basal kinase activity.  
This taken together with immunofluorescence data, indicating that the phosphorylation 
levels of myosin light chain were not altered by the downregulation of MLCK, makes it 
unlikely that reductions in internal strain on stress fibers contributed significantly to the 
results.  The introduction of the 1-41 N-terminal peptide either by peptide-induced uptake 
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or microinjection resulted in the loss of stress fibers from the central region of cells.  In 
aggregate, the results indicate that MLCK crosslinking property may be an important 
determinant of actin contractile structure. 
 
Growing evidence suggests that the ability to reorganize the contractile apparatus and 
supporting cytoskeleton plays a central role in determining the contractile properties of 
smooth muscle (Gunst et al., 1993, Shen et al., 1997, Wright and Hurn, 1994, Wright and 
Battistella-Patterson, 1998).  However, the exact nature of this remodeling and the 
mechanisms regulating cytoskeletal reorganization in contracting smooth muscle are not 
certain.  Early work indicated that blockade of actin polymerization depressed force 
development (Battistella-Patterson et al., 1997, Wright and Hurn, 1994) suggesting 
filament elongation or the generation of new filaments is an important aspect of 
contractile remodeling.  The present results further suggest that actin filament 
crosslinking by MLCK may play an important role in stabilizing actin structure in the 
precontracted cell and could contribute to actin reorganization during calcium-
independent contraction.  Based on these new findings and our previous work, we 
speculate that during Ca2+/CaM-induced activation of MLCK kinase activity there is a 
simultaneous release of cross-linked actin filaments.  Hence, in addition to activation of 
ATPase activity, MLCK may serve to both maintain actin contractile structure in the 
resting cell and release filaments for movement by myosin and force development.  In the 
absence of this crosslinking activity, the loss in actin organization in the resting cell 
inhibits cell contraction and contractile remodeling. 
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Figure Legends 
Figure 4.  Colocalization of MLCK and α-actin in untreated and PDBu (10-7M)-
stimulated A7r5 cells.  MLCK was visualized with a monoclonal anti-MLCK, clone K36.  
α-Actin was visualized with a monoclonal anti-α-actin, clone 1A4.  Secondary antibodies 
were Alexa 488 IgG and Alexa 568 IgG, respectively.  Yellow color indicates 
colocalization of the two proteins.  The white bar represents 20 µm. 
 
Figure 5.  Colocalization of MLCK and β-actin in untreated and PDBu (10-7M)-
stimulated A7r5 cells.  MLCK was visualized with a monoclonal anti-MLCK, clone K36.  
β-Actin was visualized with a monoclonal anti-β-actin, clone AC-15.  Secondary 
antibodies were Alexa 488 IgG and Alexa 568 IgG, respectively.  Yellow color indicates 
colocalization of the two proteins.  The white bar represents 20 µm. 
 
Figure 6.  Capture of donor emission before and after acceptor photobleaching in 
untreated and PDBu (10-7M)-stimulated A7r5 cells.  α-Actin was the acceptor and 
MLCK was the donor.  Note the appearance of fibers and increase in intensity of 
emission at podosomes after photobleaching indicating significant quenching of donor 
emission by the acceptor. 
 
Figure 7.  Capture of donor emission before and after acceptor photobleaching in 
untreated and PDBu (10-7M)-stimulated A7r5 cells.  β-Actin was the acceptor and MLCK 
was the donor.  Note the appearance of fibers after photobleaching indicating significant 
quenching of donor emission by the acceptor. 
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Figure 8.  Control experiments examining the responsiveness of the FRET system in 
different conditions of protein-protein association.  A)  Positive control, either α-actin (a) 
or β-actin (b) were stained with both Alexa 488 (donor) and 568 (acceptor) fluorophores.  
Images (488 nm) were captured before and after photobleaching and the difference in 
their emission intensities was obtained using Paint Shop Pro V.7.04.  B) Negative 
control, α-actin (c) or β-actin (d) were labeled with Alexa 568 (acceptor) with the α-
subunit of the calcium-sensing receptor was stained with Alexa 488 (donor).  As 
expected, this combination produced no FRET effect. 
  
Figure 9.  a.)  Western blot analysis and b) bar graph of results from siRNA 
downregulation of MLCK in A7r5 cells.  Non-targeting siRNA and siRNA-Lamin A/C 
were employed as negative and positive controls, respectively.  GAPDH was probed to 
normalize for differences in protein loading.  The bar graph indicates the averages from 
four individual experiments.  c) In addition to Western blot analysis, whole cell 
immunofluorescence was compared between negative controls and MLCK-siRNA treated 
cells as a measure of MLCK downregulation.  Red indicates MLCK, whereas blue color 
indicates nuclei stained with TO-PRO-3 dye. 
 
Figure 10.  Immunolocalization of MLCK with α- or β-actin in nontargeting siRNA 
(negative control) and MLCK siRNA-transfected A7r5 cells under unstimulated 
conditions.  MLCK was visualized with a monoclonal, anti-MLCK antibody (K36 clone) 
followed by an Alexa 568 IgG secondary antibody.  α-Actin and β-actin were visualized 
with a monoclonal anti-α-actin (1A4 clone) and a monoclonal anti-β-actin (AC-15 clone) 
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followed by an Alexa 488 IgG secondary antibody.  Confocal settings for the MLCK 
panel were kept constant for the different treatments.  White bar represents 40 µm.      
 
Figure 11.  Immunolocalization of MLCK with α- or β-actin in nontargeting siRNA 
(negative control) and MLCK siRNA-transfected A7r5 cells under PDBu (10-7M)-
stimulated conditions.  MLCK was visualized with a monoclonal, anti-MLCK antibody 
(K36 clone) followed by an Alexa 568 IgG secondary antibody.  α-Actin and β-actin 
were visualized with a monoclonal anti-α-actin (1A4 clone) and a monoclonal anti-β-
actin (AC-15 clone) followed by an Alexa 488 IgG secondary antibody.  Confocal 
settings for the MLCK panel were kept constant for the different treatments.  White bar 
represents 40 µm.   
 
Figure 12.  Peptide-induced uptake of 1-25, 26-41, and 1-41 peptides of the N-terminus 
of MLCK.  Peptides were conjugated to a peptide derived from Drosophila Antennapedia 
homeodomain protein to facilitate uptake and incubated with cells for 30 minutes.  An α-
actin FITC antibody (clone 1A4) was used for visualization of actin filaments.  In a, b) 
A7r5 cells incubated with 1-25 peptide.  c, d) A7r5 cells incubated with 26-41 peptide.  e, 
f) A7r5 cells incubated with 1-41 peptide.  
 
Figure 13.  Microinjection of A7r5 cells with 1-41 peptide and an Alexa 594 fluorescent 
tracer.  Control cells were injected with Alexa 594 tracer in a 200 mM K+ buffer solution 
while experimental cells included the 1-41 peptide.  α-Actin staining was performed with 
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FITC-conjugated antibody (clone 1A4) and used for visualization of actin filaments.  
White bar represents 20 µm. 
 
Figure 14.  Time lapse phase-contrast microscopy for negative control and MLCK-
siRNA transfected A7r5 cells.  Cells were treated with PDBu (10-7M) and cell images 
were obtained every 10 minutes for a total time of 140 minutes. 
 
Figure 15.  a.)  (MLC-P) at the serine-19/20 site in A7r5 cell negative control and 
MLCK-siRNA treated groups.  Cells were treated with PDBu (10-7 M) for 30 minutes and 
imaged with identical confocal settings for all groups.  Scale bar represents 20 µm.  b.)  
Bar graph analysis of (MLC-P)/cell area for the various treatment groups.  Significant 
differences between the negative control and the MLCK-siRNA groups are reported at 
p<0.05. 
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Table 3.  FRET values for % increase in donor fluorescence following photobleaching of 
acceptor molecules.   
a.  Actin/MLCK % Increase in Fluorescence 
Control Cells  
     α-actin (N=20) 13.2 ± 1.3 
     β-actin (N=20) 14.9 ± 1.4 
PDBu-treated Cells (10-7M)  
     α-actin (N=20) 24.7 ± 1.8* 
     β-actin (N=20) 12.9 ± 0.9 
  
b.  Positive Control  
     α-actin (N=15) 82.5 ± 3.1 
     β-actin (N=5) 43.9 ± 4.1 
  
c.  Negative Control  
     α-actin (N=10) -1.5 ± 5.2 
     β-actin (N=10) -3.0 ± 5.2 
An asterisk indicates a significant difference between control versus PDBu-treated cells, 
p<0.05.  Values are means ± SE.  Note:  a) Values indicating actin/MLCK association in 
control and PDBu-treated A7r5 cells.  b)  Positive control in which both donor and 
acceptor fluorophores were labeled to anti-α-actin or anti-β-actin antibodies.  c)  
Negative control in which α-actin or β-actin interaction with a plasma membrane-bound 
calcium channel protein was evaluated. 
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Table 4.  Whole cell immunofluorescence pixel counts in negative control and MLCK-
siRNA transfected A7r5 cells stained for MLCK. 
a. Average Intensity Pixel Count  
Negative Control 1715 ± 62  
MLCK-siRNA 945 ± 65  
   
b. Range of Values 
Pixel Counts 
% of Cells 
Negative Control           MLCK-siRNA 
>3000 5.7 1.0 
>2000 21.3 7.2 
>1000 69.7 19.5 
>500 3.2 49.5 
<500 0 22.6 
Table 4a values are means ± SE. 
 
 
 
 
 
 
Table 5.  The percent of cells forming podosomes in response to 10-7 M phorbol 12,13-
dibutyrate in negative controls and MLCK-siRNA transfected A7r5 cells.   
Treatment α-Actin β-Actin 
Negative Control 50.2 ± 5.3 23.8 ± 2.6† 
MLCK-siRNA 15.3 ± 2.6* 7.9 ± 1.7* 
An asterisk (*) or (†) indicates a significant difference between negative control versus 
MLCK-siRNA and α- versus β-actin, respectively, p<0.05.  Note: Cells were 
immunostained for either α-actin or β-actin.  Values are means ± SE and represent the 
average from a minimum of 500 cells obtained in four independent experiments. 
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Abstract 
 
Myosin light chain kinase (MLCK) is a multifunctional protein with the ability to bind to 
actin stress filaments at its N-terminus.  However, it is unknown how the protein-protein 
interaction occurs in contracting rat aorta.  Therefore, we used confocal microscopy and 
fluorescent resonance energy transfer (FRET) to better understand the interaction of 
MLCK with actin stress filaments during phorbol 12, 13-dibutyrate (PDBu)-induced 
contractions.  MLCK/α-actin did show a significant increase in interaction after 10 
minutes of stimulation with PDBu.  This interaction decreased midway through 
contraction and returned to baseline once plateau of contraction had occurred.  The 
MLCK/β-actin interaction was unchanged at each point of contraction except during the 
plateau in force generation.  This data was supported with co-immunoprecipitations 
suggesting that MLCK interacts differently with the two predominant isoforms of actin in 
rat aorta during contraction and remodeling of the cytoskeleton.   
 
 
 
 
 
 
 
 
 
Keywords:  FRET, phorbol, remodeling, cytoskeleton 
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Introduction 
Myosin light chain kinase (MLCK) is a serine/threonine protein kinase which 
phosphorylates the regulatory light chain (RLC) of myosin at the serine-19 site (Kamm 
and Stull, 1985).  Recently, it has been established that MLCK binds to actin filaments 
via its N-terminus with an amino acid motif (DVRXXL) and bundles actin filaments in 
vitro (Gao et al., 2001).  Bundling of actin is abolished upon activation of the calcium-
calmodulin (Ca2+/CaM) complex; however, certain contractile agonists activate smooth 
muscle tissue without a concomitant increase in calcium or RLC phosphorylation (Deng 
et al., 2001, Fukuzaki et al., 1992, Miura et al., 1997, Oishi et al., 1991).  One contractile 
agonist that falls into this category is phorbol 12,13-dibutyrate (PDBu).  PDBu, a tumor 
promoter, activates protein kinase C-α (PKC-α) which activates C protein inhibitor-
17kDa (CPI-17) and causes inhibition of myosin light chain phosphatase (Vorotnikov et 
al., 2002).  Earlier studies have shown PKC-α translocation to the plasma membrane and 
actin remodeling to structures referred to as podosomes in the A7r5 smooth muscle cell 
line under PDBu stimulation (Fultz et al., 2000, Li et al., 2001a).  MLCK is also localized 
to the podosome and shows increases in α-actin interaction; however, β-actin did not 
show any increase in interaction (unpublished observations).  siRNA studies have shown 
that MLCK is needed in the formation of podosomes (unpublished observations).  Other 
proteins which also bind to actin filaments (calponin and caldesmon) have been shown to 
be important for the development of podosomes in A7r5 cells (Eves et al., 2006, Gimona 
et al., 2003).  However, it is not known if information from cultured cells can be applied 
to smooth muscle cells in aortic tissue.  Therefore, these studies were performed to 
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provide information about the PDBu-induced contraction and the nature of protein-
protein interaction between MLCK and α-/β-actin in the rat aorta. 
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Materials & Methods 
Chemicals.  Unless otherwise stated all reagents were purchased from Sigma (St. Louis, 
MO). 
 
Immunohistochemistry.   Rat aortae were hung and contracted as described previously 
(Wright and Hurn, 1994).  Aortae were removed and cut along the long face of the vessel 
(longitudinal cut) as well as kept intact and cut in cross-section.  No differences in 
protein-protein interaction were observed between the different sections and therefore 
data were pooled.  After contraction with PDBu for 10, 20 minutes or until contraction 
reached plateau, the tissues were spread on aluminium foil and snap frozen in liquid 
nitrogen.  Tissue was then kept in a -70oC freezer until sectioning could be performed.  
Tissue sections were cut on an IEC cryotome in 8 micron sections and placed on poly-L-
lysine coated slides.  Sections were fixed and permeabilized by ice-cold acetone for 1 
minute and rinsed three times in PBS/0.5% Tween-20 (PBS-T), pH 7.5.  Tissue was then 
pre-blocked with 5% nonfat milk and rinsed with PBS-T before applying the first primary 
antibody at a concentration of 1:500 overnight at 4oC (MLCK, K36 clone).    The 
secondary antibody, Alexa 488 IgG (Molecular Probes, Eugene, OR), was applied at a 
concentration of 1:250 for 1 hour in PBS.  The tissue sections were pre-blocked again to 
remove excess secondary antibody and rinsed with PBS/0.5% Tween-20.  Actin or 
myosin was then probed (α-actin, clone 1A4) (β-actin, clone AC-15) (myosin, clone 
C5C.S2, Covance) at a concentration of 1:500 for 1 hour.  Alexa 568 IgG (for actin) or 
Alexa 546 IgM (for myosin) was applied at a concentration of 1:250 for 1 hour.  Cell 
nuclei were stained with TO-PRO-3 (Molecular Probes) at a 1:250 concentration for 1 
hour.  Tissues were rinsed, placed in Gelmount (Biomeda Inc, Foster City, CA) and 
coverslips applied (24 x 50mm, thickness 1, Fisher Inc., Chicago, IL).  Positive and 
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negative controls were treated in the same manner, however positive controls had both 
fluorophores (Alexa 488 and Alexa 568) used to target the single primary antibody.  In 
the negative controls, cholera toxin subunit-B was used to probe the lipid bilayer (Alexa 
488 conjugate 20 µg/mL, Molecular Probes, Eugene OR) and actin was then probed with 
an Alexa 568 fluor.  No colocalization was seen with the negative controls. 
 
Confocal/FRET Microscopy.  Immunostained tissues were mounted on a Nikon Diaphot 
microscope and confocal microscopy was performed with a BioRad Model 1024 
scanning system equipped with a krypton/argon laser.  For FRET analysis, MLCK was 
labeled with Alexa 488 and served as the donor component of the system.  α-Actin, β-
actin, and myosin were labeled with Alexa 568 or Alexa 546 and served as the acceptor 
molecules.  The donor molecule (MLCK) was directly excited and the resulting emission 
was obtained with a 522DF32 bandpass filter.  However, a portion of the energy of 
emission was transferred to neighboring Alexa 568 fluorophore resulting in emission that 
was captured on a second channel with a HQ598/40 bandpass filter.  Subsequently, the 
sample was excited at the 568 nm laser line at 100% power to photobleach the acceptor 
(α-actin, β-actin) molecule and a second image of the cell was acquired again at the 488 
nm laser line with the multichannel set to obtain MLCK fluorescence (522DF32) and to 
verify the absence of acceptor label 568 emission (HQ598/40).  An intensity profile was 
generated for each image (Image J Software, NIH) and the resulting plot was analyzed 
with Peakfit V4.11 software (SPSS Science, Richmond, CA) to obtain the area under the 
curve.  The values were then used to calculate the increase in fluorescence intensity after 
photobleaching.  Because resonance energy transfer can only occur if the donor and 
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acceptor molecules are sufficiently close to one another; the resulting values were 
analyzed in comparison of treated and control cells as an index of  % increase in donor 
fluorescence for MLCK or examined as % of control (Table 6).   
 
Tissue Co-immunoprecipitations.  Rat aortae were homogenized (7-9 aortic rings for 
each treatment) using a Con-Torque Power Unit (Eberbach Corp., Ann Harbor, MI) in 
1.5 mLs of lysis buffer (10 mM MOPS, 1% NP-40, 5 mM EDTA, 0.5 mM EGTA, 1 mM 
DTT, 50 mM MgCl2, 300 mM NaCl, 1 mM PMSF, 50 µg/mL leupeptin, chymostatin, 
and pepstatin A) for a period of 2-3 minutes and placed on ice.  Tissue lysate was then 
sonicated for 10 seconds on a high setting and centrifuged at 14,000 rpm for a period of 5 
minutes to clear solution of cellular debris.  Supernatant was kept at -70°C until BCA 
analysis (Pierce, Rockford, IL) could be performed.  Protein concentration was 
determined and equal amounts of sample were loaded onto Protein A/G beads (Pierce, 
Rockford, IL) conjugated to anti-MLCK antibodies (clone K36) in Immunopure A 
Binding Buffer (Pierce) overnight at 4°C.  Samples were centrifuged (1000 g) for 1 min 
and rinsed with PBS/0.02% sodium azide six times to rid sample of non-specific protein.  
Samples were treated with 2X SDS-sample buffer and boiled for a period of 10 minutes.  
The supernatant was subjected to 12% SDS-PAGE and probed with either α- or β-actin 
antibodies.  PVDF membranes were treated with ECL reagents and scanned using an 
Epson 2580 photo scanner.  Autoradiograms were evaluated using Image J software. 
 
Statistics.  All experiments were performed in triplicate unless otherwise indicated.  
Differences between treatment groups were evaluated by Student’s t-test and one-way 
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ANOVA using Sigma Stat V.2.03 (SPSS Science Inc., San Rafael, CA).  Differences 
were considered significant at p<0.05.  Results are presented as means ± SEM. 
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Results 
Protein-protein interaction has been studied extensively using yeast two-hybrid systems; 
however, FRET allows for the quantitative measurement of protein interaction in the 
cell’s natural environment.  This proves to be advantageous when studying cells under 
contractile stimulation.  In order to calibrate our FRET system, we used positive and 
negative controls to find our maximum and minimum FRET response (Figure 16).  Our 
positive control values were higher than our maximum experimental values for MLCK 
and actin (% increase in donor fluorescence, positive control α-actin 249.7 ± 12.2 versus 
MLCK/α-actin 10 minute stimulation, 207.8 ± 13.9; positive control β-actin 221.4 ± 9.1 
versus MLCK/β-actin zero timepoint 153.1 ± 3.5).  This held true for myosin as well 
(positive control myosin, 188 ± 9.1 versus MLCK/myosin zero timepoint 102.4 ± 8.3).  
The cholera toxin subunit-B (CT-B) was utilized to label lipid in the membranes of 
smooth muscle cells and was not shown to colocalize with either actin or myosin inside 
of the cell (data not shown).   
 
In order to gain perspective into cell orientation and size, cell nuclei were labeled in our 
samples.  It was found that MLCK and α-actin had high levels of colocalization ten 
minutes into the PDBu contraction (Figure 17A).  We also obtained samples twenty 
minutes after the zero timepoint as well as during the plateau phase of smooth muscle 
contraction (Figure 17B).  MLCK/α-actin interaction increased during the 10 minute 
stimulation and fell back to control levels during 20 minutes and plateau (Table 6).  
These data were in agreement with colocalization micrographs and co-
immunoprecipitations (Figure 17, 19).  The MLCK/α-actin interaction that was evident in 
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co-immunoprecipitations was compared to the input of actin (tissue lysate) that was 
placed in the system.  The trend was again seen during the 10 minute stimulation (Table 
7).  It is interesting to note that MLCK interacts with only a small portion of the entire 
actin pool; however, it has been noted in other studies that this interaction is important in 
cytoskeletal remodeling and contraction of the smooth muscle cells (Bao et al., 2002, 
Kishi et al., 2000). 
 
Evaluation of the MLCK/β-actin interaction was strikingly different.  FRET values 
indicated that MLCK/β-actin interaction did not change significantly until plateau was 
achieved (Table 6).  When these data were compared to co-immunoprecipitations, the 
studies did not show a dramatic change in endpoint data when compared to controls 
(Figure 19B).  It was evident that when the MLCK/β-actin interaction was compared to 
the input of actin into the system, the amount of MLCK that was associated with β-actin 
was less than the MLCK and α-actin interaction (Table 7 and Figure 19A).  This also 
correlated with the FRET values obtained in zero timepoint tissues (MLCK/α-actin 179.6 
± 17.2; MLCK/β-actin 153.1 ± 3.5, % of increase in donor fluorescence). 
 
Our plans will be to study other actin-binding proteins (e.g. calponin and caldesmon) to 
see how these interactions occur with actin as well.  FRET and co-immunoprecipitations 
for MLCK/myosin did not show interaction therefore it was not included in the present 
data set.  Collectively, the data suggest that MLCK interaction with actin isoforms differs 
depending on the isoform studied and may be important in understanding contractile 
mechanisms of smooth muscle.  Finally, observation of cells in the rat aorta indicated that 
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MLCK and α-actin interact at discrete microdomains in the periphery of the cell (Figure 
19).  A7r5 cells also show MLCK/α-actin interaction in adhesive structures in the 
periphery of the cell referred to as podosomes.  However, it remains to be determined if 
vascular smooth muscle cells contained within an extracellular matrix act in a similar 
fashion to those during contraction in cell culture. 
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Discussion 
Smooth muscle contraction has been studied extensively, but only recently have 
improvements in imaging allowed for better measurement of protein-protein interaction.  
FRET gives the ability to measure interaction within the cell and monitor differences 
upon contractile stimulation (Isotani et al., 2004).  Here we looked at two different 
isoforms of actin and myosin II to better understand their interaction with MLCK.  In 
vitro data has shown that MLCK has a high affinity actin-binding site located within the 
N-terminus of the molecule (Hayakawa et al., 1999b).  Upon activation of the Ca2+/CaM 
complex, the ability to bundle actin is destroyed thus allowing myosin II to cycle along 
the thin filament.  PDBu, on the other hand, does not induce a high calcium response and 
the contraction is extremely slow in contrast to high calcium agonists such as A23187 or 
potassium depolarization (Li et al., 2001b).  MLC phosphorylation also undergoes only a 
slight increase in the initial stages of PDBu contraction and it is thought that other 
kinases play a role in the calcium independent contraction (e.g. Rho-kinase and Integrin-
linked kinase)(Chrzanowska-Wodnicka and Burridge, 1996, Deng et al., 2001, Miura et 
al., 1997).  Therefore, the ability for MLCK to bundle actin should remain intact during 
the PDBu-induced contraction.  FRET and co-immunoprecipitations indicated this with 
MLCK showing enhanced and diminished ability to bind to actin during certain aspects 
of the PDBu contraction.  The homology of α- and β-actin is >95%, leaving a 10-12 
amino acid residue portion difference in the N-terminus of the two proteins.  Whether 
MLCK interacts with this specific N-terminal sequence is still not known at this time. 
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Fultz et al. (2000), have shown that α-actin and β-actin remodel differently in the 
presence of phorbol esters in the A7r5 smooth muscle cell line.  α-Actin typically 
remodels into adhesive structures called podosomes while the β-actin remains in 
filamentous form.  The tissue data suggest a similar remodeling phenomenon; however, 
aortic tissue showed a quicker response (within 10 minutes) of the MLCK/α-actin 
interaction, whereas the MLCK/α-actin interaction in A7r5 cells showed enhancement of 
interaction after a 30-minute stimulation (unpublished observations).  The reason for the 
time difference is unclear, but the data suggest recruitment of MLCK to the α-actin 
filaments during the PDBu-induced contraction.  
 
The MLCK/β-actin interaction remained unchanged during the development of tension in 
rat aorta, perhaps indicating its role as a structural scaffold allowing the α-actin to 
remodel with MLCK into microdomains in the periphery of the cell.  Despite the 
conflicting data for the plateau phase of contraction, it has been shown that MLCK binds 
to both α-actin and β-actin filaments.  When comparisons were made on the amounts of 
α-actin that interacts with MLCK, a 12-20% interaction was discovered with the high 
range occurring during the 10-minute stimulation.  The interaction between MLCK and 
β-actin showed a 3-8% range and these values decreased as plateau was achieved.  
Although these results could be due to differences in antibody affinity, it is interesting to 
note that α-actin and β-actin ratios have been found in similar proportions in other 
studies (Otey et al., 1987, Otey et al., 1988). 
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MLCK and its ability to bind to myosin II at its C-terminus has been documented, but the 
affinity is rather weak in comparison to actin (Stull et al., 1998).  Although we noted a 
FRET response in our positive controls for myosin, we could not see a significant 
increase in FRET or interaction via co-immunoprecipitations for the MLCK/myosin 
interaction.  Reasons for this could be that the MLCK/myosin interaction is transient or 
was abolished due to immunohistochemical/co-immunoprecipitation protocols.  Another 
could be that direct MLCK/myosin interaction is not needed for the PDBu-induced 
contraction.   
 
Taken together, the data suggest that MLCK interacts differently with α- and β-actin acts 
during PDBu-induced contraction.  This difference supports earlier studies in actin 
isoform-specific remodeling in the A7r5 smooth muscle cell line.   
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Figure Legends 
 
Figure 16.  A.)  Immunohistochemical staining of rat aortae for α-/β-actin, myosin, and 
cholera toxin subunit-B (CT-B) “before photobleaching of acceptor” and “after 
photobleaching of acceptor.”  B.)  Percent increase in donor fluorescence for positive and 
negative controls.  Positive controls were one primary antibody targeted with two 
fluorophores (Alexa 488 and Alexa 568).  Negative controls were CT-B targeted with the 
acceptor being either α- or β-actin.  No colocalization was evident with negative controls.  
Actin and myosin micrographs are in cross-section.  CT-B micrograph is in longitudinal-
section.  The white bar represents 20 µm. 
 
Figure 17.  A.)  Triple staining of MLCK (green), α-actin (red), and nuclei (blue) in 
longitundinal cut of rat aorta from control (unstimulated) and 10 minute exposure to 
PDBu (10-7 M).  Color figure legend is found under “contracted” confocal image.  
Yellow represents colocalization of MLCK and α-actin.  Magenta represents 
colocalization of α-actin and cell nuclei.  White arrows represents the direction in which 
the cells are oriented.  Note the decrease in cell length in the contracted aortic cells.  The 
white bar represents 20 µm.  B.)  Tissue was evaluated at time zero (A), 10 minutes after 
exposure to PDBu (B, start), 20 minutes after exposure to PDBu (C, midpoint) and at 
endpoint of contraction (D, plateau). 
 
Figure 18.  Increased magnification of rat aorta depicting a single cell.  Triple staining of 
MLCK (green), α-actin (red), and nuclei (blue) in longitundinal cut of rat aorta.  Color 
figure legend is found under “merge” confocal image.  Note the colocalization between 
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α-actin and MLCK at discrete microdomains in the periphery of the cell.  Micrograph 
labeled “Difference” is the image subtraction of the “Before photobleach” image and the 
“After photobleach” image.  Note the areas of colocalization indicate a positive FRET 
value.  Scale bar represents 5µm. 
 
Figure 19.  A.)  Immunoblots of MLCK co-immunoprecipitations probed for α- and β-
actin.  “TL” represents tissue lysate or input into the system with “C” representing 
(control), “10” (10 minutes after PDBu), “20” (20 minutes after PDBu), and “End” 
(endpoint of contraction).  B.)  Line graph analysis of treatment groups based on percent 
of control.  Asterisk represents a significant difference between control and treatment 
with p<0.05. 
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Table 6.  FRET analysis of MLCK/Actin interaction in rat aorta.   
 α-actin/MLCK β-actin/MLCK 
Control (zero timepoint) 100 ± 3.5 100 ± 2.6 
10 min. (start) 117.1 ± 4.1* 95.1 ± 1.7 
20 min. (midpoint) 91.1 ± 2.2 97.0 ± 2.5 
Endpoint (plateau) 95.1 ± 2.3 72.6 ± 0.9* 
Data are presented as percent of control with values summarized as means ± SEM.  
Asterisks represent a significant difference between control and treatment group with 
p<0.05. 
 
 
 
 
Table 7.  Percent of MLCK and α-/β-actin interaction in comparison to tissue lysate. 
 α-actin/MLCK β-actin/MLCK 
Control 11.3 ± 2.9 5.8 ± 2.6 
10 min. 16.9 ± 5.9 5.5 ± 2.3 
20 min. 11.8 ± 5.1 3.9 ± 1.6 
Endpoint 12.0 ± 4.3 3.4 ± 1.4 
Data are presented as means ± SEM. 
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Figure 16. 
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Figure 17. 
 
 
 
Figure 18. 
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Figure 19. 
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Chapter Four 
Summary and Conclusions 
General Discussion 
 
 Here we examined the role of MLCK and its binding to α- and β-actin in the A7r5 
cell and rat aorta.  MLCK did show significant binding to α-actin and was located in the 
podosome of the A7r5 cell.  RNAi assays revealed that MLCK was necessary for 
podosome formation and filament stabilization.  Despite MLCK downregulation, RLC 
phosphorylation was not affected by the siRNA indicating that the kinase domain of 
MLCK was not influential in podosome development or filament stabilization.  This is 
the first study to link the N-terminus of MLCK as a necessary component in the 
formation of podosomes and binding to both α- and β-actin. 
 MLCK also shows interaction with both α- and β-actin in rat aortae.  FRET 
analysis and co-immunoprecipitations confirm differential binding during the time course 
of the PDBu-induced contraction.  These studies suggest that MLCK may be recruited to 
actin filaments and this may contribute to force development and tension maintenance in 
vascular smooth muscle.   
In Figure 20, a model is proposed to help explain how the MLCK/α-actin 
interaction takes place and disengagement of MLCK to the α-actin filament in the 
presence of Ca2+/CaM.  The diagram suggests that actin and myosin are kept in register 
with one another through MLCK binding and that MLCK will allow for power stroke 
along one α-actin filament while remaining bound to the other β-actin filament.  This 
model could explain why α-actin remodels into podosomes while β-actin remains in 
filamentous form in the PDBu-induced contraction. 
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 In the resting configuration prior to the initiation of contraction (Figure 20A), 
MLCK would act to cross-link actin filaments, stabilizing the contractile cytoskeleton in 
a “pseudo-sarcomere” with actin filaments in register with myosin filaments.  In the 
presence of Ca2+/CaM (Figure 20B) concurrent with the activation of MLCK kinase 
activity, the loss of binding at the Ca2+/CaM-sensitive site would serve to destabilize 
actin filament arrangement allowing filament sliding and freeing actin filaments for 
reorganization during cell shortening. 
 The results suggest that α-actin is more susceptible to MLCK/Ca2+-CaM 
destabilization indicating future studies to investigate the dynamics of MLCK binding 
with α- and β-actin filaments.  In combination with the present findings, the model 
further predicts that PKC-mediated events may contribute significantly to α-actin  
remodeling during contraction and could involve modulation of MLCK cross-linking 
activity. 
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Figure 20.  Proposed model for the MLCK/actin interaction in vascular smooth muscle.  
Note that in the absence of Ca2+/CaM (A), the Ca2+/CaM-sensitive and –insensitive sites 
are bound to two actin filaments.  This protein conformation positions the myosin 
filament and α-actin filament so that there is no interaction.  Upon calcium influx and 
CaM activation (B), MLCK undergoes a conformational change to disengage the 
Ca2+/CaM-sensitive site allowing for myosin and α-actin interaction and subsequent 
power stroke to occur.  Note that while the α-actin filament moves to the right, the β-actin 
filament is kept in register with the myosin filament.   
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Future Work 
The possibility that podosomes may be similar or identical to invadopodia 
suggests that smooth muscle has directed cellular motility after breakdown of the ECM.  
This migration has been documented in cardiovascular problems such as aneurysm and 
atherosclerosis.  Work by the Mak lab, using the explant method, has indicated that 
vascular smooth muscle cells display podosomes (Webb et al., 2006).  It has also been 
documented that inhibition of MMPs through the antibiotic, doxycycline, decreases the 
severity and incidence of abdominal aortic aneurysm (AAA) (Manning et al., 2003).  It 
will be of interest to see if the structure and function of podosomes in the A7r5 cell are 
similar to those in vascular smooth muscle and if inhibition of podosomes will decrease 
or abolish the severity of cardiovascular diseases. 
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